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Background: The skills and capacities developed during early childhood are the 
foundation for a child’s future academic functioning, economic productivity, and lifelong health 
and mental health. When young children have developmental delays or disabilities, early 
identification and intervention lead to better outcomes; however, only a minority are identified 
before school entry. Primary care is an important setting for identification of developmental and 
behavioral conditions as most young children attend well-child visits regularly and parents 
expect developmental guidance from pediatricians. Two key pediatric preventive services are 
recommended: developmental monitoring/surveillance at every well-child visit and 
developmental screening at 9 months, 18 months, and 30 months (or 24 months) or if a concern 
is raised at any other visit. Research has shown that when health care providers conduct 
screening (using a standardized, validated screening tool), they are more likely to identify 
developmental and behavioral conditions than when they conduct monitoring (eliciting parent 
concerns and using observation and clinical judgment).  In addition, health care providers are 
less likely to identify developmental and behavioral conditions among black children, Latino 




Aims: To describe rates of developmental and behavioral screening and monitoring 
across subgroups of children. To determine whether there are racial/ethnic disparities in receipt 
of screening and monitoring. To describe the variation in screening and monitoring rates across 
states and identify state-level policy factors that may influence screening rates. 
Methods: We used data from the 2011/2012 National Survey of Children’s Health 
(NSCH) for children 5 years and under who saw a health care provider in the previous 12 
months. Patterns in children’s receipt of screening and monitoring were assessed, including 
changes from the 2007 NSCH. Multilevel logistic regression models evaluated socio-
demographic, health care and developmental risk factors associated with children’s receipt of 
screening and monitoring. Policy data from a 2011 survey of state Medicaid officials were used 
to examine the association between receipt of screening and two Medicaid policies. 
Results: Nationally, fewer than one in three children 5 years and under (30.8%) were 
reported to have received a parent-completed screening in the previous 12 months, with rates 
varying from 17.5% in Mississippi to 58.0% in North Carolina. Rates of developmental and 
behavioral monitoring varied from 39.8% in Mississippi to 66.6% in Vermont, with a national 
average of 51.8%. Forty percent of children received neither monitoring nor screening. Children 
under 3 years of age were more likely to receive screening and monitoring than were preschool-
age children. There were no differences in receipt of screening by sex, race/ethnicity, household 
income, insurance type, or access to a patient-centered medical home. In contrast, there was 
considerable variability in developmental and behavioral monitoring across subgroups of 
children. Black children and Latino children from non-English speaking homes had lower odds 
of receiving monitoring that white children. Children in a medical home were almost twice as 




screening rates increased overall but the percent change was lower for black children than for 
white children and for children living in poverty than for higher income children. Some states 
were more successful at increasing their screening rates from 2007 to 2011/12 than others, with 
Massachusetts showing the largest increase. State Medicaid policies to require screening and to 
pay an additional fee for screening were not associated with increased odds of children on 
Medicaid being screened. 
Conclusions: There are significantly lower rates of screening and monitoring of young 
children’s development and behavior than recommended in pediatric practice guidelines. 
Monitoring, specifically eliciting parent concerns, is unevenly applied across patient populations. 
By using standardized, parent-completed screening tools, it is possible to access parent-reported 
information directly rather than relying on the provider to elicit parent concerns. Screening could 
therefore be a means to reduce racial/ethnic disparities in identification of developmental and 
behavioral conditions and potentially reduce disparities in young children’s outcomes. Children 3 
to 5 years of age had significantly lower screening rates than children under 3, suggesting the 
importance of targeted efforts to increase screening for the preschool age group to ensure 
identification of developmental and behavioral concerns before school entry. Certain states are 
more successful in increasing screening rates than others; further study of their state-level 
policies is warranted. 
Policy Implications: It is a public health priority to identify developmental and 
behavioral conditions in an accurate, timely, and equitable manner. States have access to several 
important policy levers to incentivize health care providers to incorporate screening into their 
practices. Screening mandates may be particularly important, along with provider training and 




with a requirement to track and report screening. Reimbursement for screening may be used 
across Medicaid fee-for-service and Medicaid managed-care systems. It is important to promote 
linguistic and cultural competence in screening and engage parents to act on the results. Use of a 
combination of state-level universal screening policies as well as targeted strategies for specific 
populations may increase identification of developmental and behavioral conditions among all 
young children while helping to reduce disparities in identification. This would help ensure 
young children are linked to appropriate interventions that improve their developmental and 
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
 
PUBLIC HEALTH SIGNIFICANCE OF DEVELOPMENTAL AND BEHAVIORAL SCREENING 
Early identification of, and intervention for, developmental and behavioral concerns 
among young children can improve their educational, health, and mental health outcomes. This is 
a public health priority: the capacities developed during early childhood lay the foundation for 
later academic achievement, economic productivity, and lifelong health and mental health.1–5 
Most children move along a developmental trajectory whereby they reach developmental 
milestones within specific age ranges. These milestones are categorized within several 
developmental domains, including physical, cognitive, communication, social–emotional, and 
self-help.3,6 However, some young children experience delays or difficulties achieving these 
milestones. In the United States, approximately 17% of children 3–17 years of age and 13% of 
children under 3 years of age are estimated to have developmental delays or disabilities, such as 
autism, an intellectual disability, and attention deficit hyperactivity disorder.7,8  
Currently, developmental disabilities are unequally distributed across the U.S. 
population. Children on Medicaid have nearly twice the prevalence of any developmental 
disability compared to those with private insurance, and children living below the federal poverty 
level also have a higher prevalence of developmental disabilities.9 Strong scientific evidence 
shows that young children’s development is fundamentally affected by social disadvantage and 
by stresses in their family and caregiving environment.5, 10 There are effective evidence-based 
interventions for children with developmental delays and disabilities that can improve their 




development lead to improved learning abilities, self-regulation, and resilience to adversity. They 
also prevent later mental health problems,11,12 and are cost-effective.13–15 
Early identification of developmental difficulties followed by appropriate intervention 
has been found to improve long-term academic, social, and health outcomes, with benefits to 
children, families, and society.4,16 In contrast, failure to identify and respond to developmental, 
emotional, and behavioral problems can lead to school failure, the development of more severe 
disorders, family disruption, and more costly interventions later.4,17 In the United States, children 
who are identified as having, or being at risk for, developmental delay are eligible for services 
under the Individuals with Disabilities Education Act (IDEA). IDEA is a grants and civil rights 
statute, providing federal funding for the education of children with disabilities and outlining due 
process provisions to ensure children receive a free appropriate public education. The legislation 
was originally enacted in 1975 as the Education for All Handicapped Children Act, renamed 
IDEA in 1990, and amended in 1997 and in 2004.18,19 Infants and toddlers (under 3 years) with 
disabilities and their families receive Early Intervention (EI) services under IDEA Part C. 
Children and youth (3–21 years) receive special education and related services under IDEA Part 
B. The federal legislation provides for grant programs to states to support EI services for infants 
and toddlers with disabilities and special education for preschool and school-aged children with 
disabilities, and governs how states and public agencies provide EI, special education, and 
related services. 
Unfortunately, only 20% to 30% of young children with developmental problems are 
identified by the time they enter school.20,21 This means that large numbers of children who need 
services do not receive them. For example, although approximately 13% of children birth to 3 




three nationally representative household surveys estimated that the majority of children who 
need social-emotional and mental health interventions do not receive them.23 There are relatively 
higher unmet mental health needs among uninsured children23 and among children from racial 
and ethnic minorities.23–25 
It is a public health priority to identify developmental conditions in an accurate, timely, 
and equitable manner for several key reasons. First, developmental disabilities are common, 
affecting one in six children, and are often associated with lifelong functional limitations. 
Second, poor children are at higher risk of developmental disabilities and this is linked to social, 
economic, and environmental disadvantage. Third, identification is associated with higher 
likelihood of accessing care, and this is the best chance of mitigating the impact on the child, 
family, and society. Fourth, children of color and low-income children are less likely to be 
identified with developmental conditions when they exist.6 Therefore, health disparities occur on 
two levels—a higher prevalence of developmental and behavioral conditions and a lower 
likelihood of these conditions being identified among children of color and among low-income 
children. 
Developmental and behavioral screening (DBS) is an important clinical preventive 
service that can detect developmental conditions at an early stage and, when paired with referral 
and intervention, can limit functional impairments and overcome earlier negative impacts on 
development.6, 26 DBS is therefore a means to improve population health and to potentially 





DEVELOPMENTAL AND BEHAVIORAL SCREENING IN HEALTH CARE SETTINGS 
Most young children attend well-child visits in primary care, making this an ideal setting 
for the identification of developmental and behavioral problems.27,28 However, a large number of 
children with these difficulties are not identified in the primary care setting, potentially leading 
to a delay in receiving care, and to worse outcomes. In particular, primary care providers are less 
likely to identify developmental, behavioral, and emotional problems in children who are Black 
and Latino, and in children who are non-English speaking.29,30 Parentsi are the main drivers for 
their young children’s use of services, and parents’ appraisals of their children’s behavior and 
decision to access care are key factors in the help-seeking process.29,31 But parents often do not 
recognize problems in their children and, if they do, may not report them.32,33 
The primary care setting offers particular strengths and opportunities for the 
identification and management of developmental and behavioral concerns among young 
children. Nationally, a large majority of young children see a primary care physician regularly 
for well-child visits (in 2013, 92% of children 5 and under were reported by their parent to have 
had a preventive care or well-child visit in the previous year).28 Parents expect developmental 
guidance and expertise from pediatricians during these visits34 and build trusting relationships 
over the long-term with their pediatricians.17 
In 2006, the American Academy of Pediatrics (AAP) recommended developmental and 
behavioral monitoring (DBM) of all children at every well-child visit.27 DBM (also known as 
developmental surveillance) is an ongoing process over regular well-child visits to identify 
children who may have developmental problems. DBM involves a health care provider eliciting 
                                                 




and attending to a parent’s concerns about their child’s development, documenting a 
developmental history, making accurate observations of the child’s behavior, and identifying risk 
and protective factors. If the monitoring suggests risk of a developmental delay, then a 
developmental screening should be conducted. This involves using a standardized test; 
positive/concerning results should prompt referral for a full developmental evaluation to 
determine the nature of the difficulties and required interventions. The AAP guidance 
specifically notes that the physician must elicit parent’s concerns and pay them serious attention; 
if either the parent or the professional is concerned, a developmental screening should be 
conducted. In addition, the AAP recommends developmental screening using a standardized, 
parent-completed screening tool for all children (regardless of risk) during well-child visits at 9 
months, 18 months, and 30 (or 24) months.27,35 These ages were selected based on the ability to 
recognize problems with emerging skills at those ages with the aim of identifying problems as 
early as possible. At 9 months of age, it is possible to reliably identify issues relating to motor 
skills development and early social communication skills, for example, reviewing whether the 
child makes eye contact and responds to her name. At 18 months of age, motor and 
communication and language delays are more clearly evident. The AAP also advises use of an 
autism screener such as the M-CHAT during the 18-month well-child visit. By 30 months of age, 
more motor, language, social-emotional, and cognitive delays can be identified. 
The AAP recommends use of one of several standardized, validated developmental and 
behavioral screening tools for young children—multi-domain developmental screens at 9, 18, 
and 24 (or 30) months and autism-specific screens at 18 and 24 months.27, 36, 37 
A general, multidomain DBS tool assesses development on several domains (e.g., 




emotional skills). Specific screening tools focus on a specific area of development such as social 
communication skills. Tools vary in terms of administration time, costs, sensitivity and 
specificity, and cultural and linguistic appropriateness. The most well-recognized and well-
validated, general developmental screening tool is the Ages and Stages Questionnaire Third 
Edition (ASQ-3). It is available in five languages and covers the developmental domains of 
communication, fine-motor, gross-motor, personal–social, and problem-solving skills. The ASQ-
3 includes a series of age-specific questionnaires for children 4–60 months of age with 30 items 
each and an administration time of 10–15 minutes; it has moderate to high sensitivity and 
specificity, and is normed on a diverse ethnic and socioeconomic population. The ASQ:SE is a 
modification of the ASQ-3, focusing only on social–emotional skills. A recent study found that 
less than half of the children with a positive screen on the ASQ:SE would have been identified if 
they had only received the ASQ-3, suggesting it is preferable to go beyond a general screening 
tool to recognize social–emotional delays.38 A popular tool for pediatric primary care is the 
Parents’ Evaluation of Developmental Status (PEDS). It is used for children birth to 8 years, has 
10 items on a single response form used for all ages, is available in 14 languages, and has 
moderate sensitivity and specificity. There are no data on frequency of use of different screening 
tools by primary care physicians in the United States. Professional groups and state Medicaid 
agencies provide lists of acceptable tools for use, but there are no mechanisms for tracking which 
tools are actually used. Screening tools can predict risk for a disorder, but must be followed by 
an evaluation to make a diagnosis and formulate an intervention plan. 
The importance of DBS has increasingly been highlighted by the federal government and 
by professional organizations. The AAP’s practice guidelines described above were published in 




a public education campaign targeting providers and parents to support DBS.9 In 2015, the AAP 
highlighted the importance of screening for problems in social–emotional development32. The 
National Quality Forum (NQF), a partnership of government and nongovernment agencies that 
sets standards for improving the quality of health care, has endorsed measures for DBS for 
children from birth through age 5. In addition, Healthy People 202026 includes a goal to promote 
quality of life, healthy development, and healthy behaviors across all life stages, and one 
objective is to increase the proportion of children aged 10–35 months who are screened for 
developmental delays within the previous year. This objective uses data from the National 
Survey of Children’s Health to measure progress from the baseline of 22.6% in 2007 to the target 
of 24.9% in 2020. 
 
BENEFITS OF SCREENING COMPARED TO MONITORING 
Research shows that screening with a standardized tool is more effective than physician 
monitoring for the identification of developmental and behavioral concerns. When primary care 
providers do not use a standardized screening tool, but rather rely on their clinical judgment 
(even if they ask systematic surveillance questions), they are less likely to identify children in 
need of services.29, 39-43 The AAP recommends that screening instruments have at least 70% 
sensitivity.27 In contrast, a systematic review of studies on pediatric care providers’ identification 
of developmental and behavioral disorders found that providers who conducted developmental 
monitoring but did not use screening instruments were able to correctly identify 69% to 100% of 
children without a developmental–behavioral problem, but only 14% to 54% of children with a 
developmental–behavioral problem.42 A randomized controlled trial comparing DBS and DBM 




tool were twice as likely to be appropriately identified as having delays and to receive a timely 
referral to early intervention (EI) services than children who received monitoring only.43 
There is evidence that identification increases when parents report concerns about their 
children to the provider. However, soliciting parent concerns may be inadequate to detect 
behavioral problems in young children. One recent study44 found that, of the parents who 
expressed no concerns about their child’s (age 3—65 months) development, behavior, or 
learning, 18% of their children were later identified, through parent response, as being at risk on 
the Ages and Stages Questionnaire (ASQ). In addition, parents of more than half the young 
children who screened positive on the tool had not previously expressed any concern about their 
children. 
Therefore, providers may not be informed about developmental or behavioral issues by 
parents45,46 in part because parents of young children may lack knowledge about these issues or 
about the benefits of early recognition and intervention.33 Indeed, one of the ways that screening 
is beneficial is that it offers primary care physicians access to parent-reported information 
without having to elicit concerns directly from parents or relying on parents to bring up their 
concerns. Screening increases parent disclosure of problems and the attention that physicians pay 
to these problems, and in that way facilitates parent–provider communication.47,48 As such, DBS 
can be a catalyst to the help-seeking process.29 
A potential additional benefit of DBS is that it may help reduce racial/ethnic disparities in 
access to care.42,49 Providers’ ability to recognize behavioral problems may vary by a child’s 
race/ethnicity; for example, a study of pediatric primary care providers found discrepancies 
between the providers’ identification of a problem and the results of a validating screening tool 




a high level of difficulty, providers did not identify 41% of these children who identified as 
Latino/Other race/ethnicity and 32% of these children who were Black, in contrast to a much 
lower 11% of children who were White. Of the children who scored as having moderate 
difficulties, discrepancies in identification were even greater; providers did not identify 71% of 
children with moderate difficulties who identified as Latino or Other race/ethnicity and 55% of 
children who were Black; in contrast, they did not identify 27% of White children with 
difficulties.30 Findings suggested that screening, rather than monitoring, may especially increase 
identification of problems among Black and Latino children. Therefore, universal DBS, whereby 
all children receive the same assessment (that does not rely on questions asked by providers), 
could be a means to reduce racial/ethnic disparities in identification and remediation of 
developmental and behavioral concerns,29,30 provided that DBS is offered equitably to all 
racial/ethnic and economic groups. 
Although the evidence shows that identification of developmental and behavioral needs 
increases when standardized tools are used, in practice, primary care providers do not use these 
standardized instruments the majority of the time.50,51,46,52 One study found that only 23% of 
primary care providers of children birth to 3 years reported always or almost always using a 
standardized screening instrument.53 There are perceived barriers to implementing DBS, with 
providers reporting a lack of time, cost of screening, lack of trainings, and limited availability of 
referral options if a concern is identified.21,54,55 
In sum, research suggests that DBS is more effective at identifying problems in the 
general population than DBM. However, DBS is not universally administered in primary care 





POLICIES RELATING TO SCREENING 
Overview of Screening Policies 
Successful universal screening and referral of young children requires the availability of 
appropriately trained providers using standardized tools; and parents who are able to access these 
services with their children. Relevant health policies are therefore those that have an impact on 
health care provider availability and behavior, and on child and family access to health care and 
screening services. 
Public policies relevant to screening operate at the Federal, state, and local levels and 
may be used as regulatory tools to prescribe the behavior of a target group (e.g., primary care 
providers) or allocative tools to provide services and goods to certain groups (e.g., financing 
DBS or expanding Medicaid access).56,57 Private sector policies are made by health care 
organizations, accrediting bodies, and professional organizations; for example, the AAP sets the 
major practice guideline for pediatric care and recommends DBS using validated tools at 
specified ages during well visits, as discussed above.36 
Examples of policies that relate to screening are:57 
• laws mandating screening, as in New Jersey’s law requiring postpartum 
depression screening; 
• rules and regulations that interpret laws, for example, a state Department 
of Health’s interpretation of Medicaid’s Early and Periodic Screening, 
Diagnostic, and Treatment (EPSDT) benefit; 
• operational decisions, such as a state Department of Health’s decisions 




• judicial decisions, as in a court-ordered requirement for screening and 
treatment, such as occurred in Massachusetts’ “Rosie D” decision. 
States play a key role in the development and implementation of health care policy.56 
States design and administer their state Medicaid programs. They determine eligibility criteria, 
enrollment processes, and the type, amount, duration, and scope of covered services, as well as 
the rate of payments to providers (after they meet the federally mandated minimum standards on 
eligibility and covered benefits). States also help cover many public health services, often 
through local governments, including public health nursing services and home-based care. They 
support safety net hospitals and providers. States are authorized to regulate most aspects of the 
health care system. They license and oversee health care practitioners and facilities. They also 
cover much of the cost of medical education and training of health care professionals. They may, 
for example, provide incentives such as student loan repayments to students who choose primary 
care or who serve in underserved areas or they may provide incentives for practitioners to use 
electronic health records. Health insurers are regulated at the state level, and states limit the price 
and parameters of health insurance products and the actions of health insurance and managed-
care companies. States may also provide funding for health promotion and education programs 
and campaigns. 
Two Federal statutes are relevant to the provision of screening: the Patient Protection and 
Affordable Care Act of 2010 (ACA) and Medicaid’s EPSDT benefit that was first introduced in 
1967. 
The ACA contained provisions that may promote developmental screening.39 First, the 
ACA increased the number of children covered by Medicaid. Second, it increased Medicaid 




offer well-child care (note that these rate increases were temporary until 2014 and did not 
include non-physician providers of primary care such as nurses, many of whom may be involved 
in well-child care). Third, the ACA included developmental and mental health screenings as part 
of preventive care. It mandated that commercial health plans cover a range of preventive services 
for children without charging a copayment or coinsurance when provided by an in-network 
provider. This included developmental screening for children under 3 and developmental 
surveillance/monitoring for children birth to 17 years. The ACA also expanded the primary care 
workforce through loan repayment and scholarships for physicians who worked in underserved 
areas and those who chose subspecialties such as pediatric mental health.58 In addition, the ACA 
invested funds in community health centers that could increase availability of providers and 
promote the medical home model that emphasizes well-child care and developmental 
screening.39 
EPSDT is Medicaid’s long-standing childhood preventive health program that specifies 
that Medicaid-covered children should receive assessments and medically necessary services to 
promote their healthy physical, emotional, and behavioral development. EPSDT also mandates 
that children receive screenings following established periodicity schedules and all follow-up 
services (diagnostic services, health education, and health care) needed to correct illnesses and 
conditions discovered by screening services.59,60 As such, EPSDT offers children a broad set of 
benefits that cover the full range of preventive, acute care, and early intervention services. 
However, several factors limit children’s receipt of EPSDT services in practice. Not all 
Medicaid-eligible children are enrolled in Medicaid or are enrolled consistently; not all those 
enrolled see a regular health care provider for well-child visits, and, as discussed above, the use 




government employs a benchmark that 80 percent of Medicaid-enrolled children receive at least 
one screening during their first year of life and two screenings as toddlers. Nevertheless, in 2008, 
only 40 states reported that they met this benchmark for infants and 44 states met the benchmark 
for toddlers.61 States are not required to report on the types of screening tools used and whether 
they are comprehensive and validated tools. 
States differ in how they implement the EPSDT mandate, and certain state provisions are 
disincentives to screening in primary care. While developmental screenings may be reimbursable 
under Medicaid, states differ with regard to reimbursement rates, and with regard to rules about 
when to conduct screenings and which types of providers may conduct the screenings.62 They 
may also not allow multiple charges for different screening tools during one visit. Some states 
enforce bundled payments for all well-child services, thus precluding additional payments for 
screenings. Fee-for-service rates for screenings vary across states, but it is unclear how much 
Medicaid pays providers when they are in managed-care networks.39 In addition, some states do 
not require the use of specific validated screening tools.63 States also differ on whether the 
screening periodicity schedules for their EPSDT programs meet AAP guidelines. Some states 
require fewer than the recommended number of pediatric visits. For example, in 2012, 39 states 
required 4 visits for children ages 1–2 and not the recommended 7 visits.64 
Policies Influencing Provider Behavior 
States have a range of strategies at their disposal to target provider behavior and to 
increase the likelihood that providers will conduct screening.65 These include financial 
incentives, mandates, and educational initiatives.66  
In 2008, in reponse to a class action law suit (“Rosie D”), Massachusetts mandated 




by additional payments for screening as well as funding for follow-up services once children 
were referred. The Massachusetts mandate led to an increase in screening and several factors 
were associated with success: MassHealth’s engagement with health care providers during the 
planning and implementation of the policy, reimbursement for screening, and consultation and 
referral support provided to providers.67 
States can track and report screening and follow-up data to monitor these activities and 
hold health plans and providers accountable. This can lead to quality improvement activities such 
as educating providers about billing codes and procedures for screening. For example, screening 
is included as a Healthcare Effectiveness Data and Information Set (HEDIS) measure to evaluate 
health plan performance. However, these are only for Medicaid managed-care programs and only 
25 states use HEDIS meaures and not for all types of plans. 
States can partner with AAP chapters to offer training and technical assistance for 
pediatric primary care physicians.68 This includes training around appropriate coding and billing 
practices, maintaining a directory of referral agencies, and using and interpreting tools 
appropriate to the primary care setting for screening and assessment. The AAP has recognized 
the organizational challenges faced by providers. It provides guidance for primary care providers 
to address barriers to screening and to prepare their practice69 with appropriate office systems 
and procedures, knowledge of referral networks and community resources, and collaborative 
relationships. These relationships should be established with local public health agencies, early 
care and education centers, and early intervention providers, among others.70 
Policies Influencing Access to Screening 
In 2015, nationally almost half (45%) of young children under the age of 6 were covered 




income young children, including 74% of children with family incomes less than or equal to 
200% of the Federal Poverty Level ($40,320 for a family of 3 in 2016).71 
There are several mechanisms by which states regulate children’s access to publicly 
funded care.64 First, states vary in what they set as the income eligibility for Medicaid and CHIP, 
with 46 states covering children birth to 5 at or below 200% of FPL and 4 states falling below 
that. Second, states set eligibility for children with legal immigrant status, with 25 states 
providing coverage to legal immigrant children without a 5-year waiting period. A few states 
also use separate state funds to provide coverage to children with undocumented status. Third, 
states determine how often children’s eligibility for Medicaid/CHIP must be established, for 
example, 18 states require redetermination of eligibility more than once a year. In addition, states 
determine whether children can receive temporary Medicaid and CHIP coverage until their 
eligibility can be determined (“presumptive eligibility”) with only 17 states having this policy 
(some only for Medicaid and not CHIP). Further, states can automatically enroll children in 
Medicaid/CHIP when they are eligible for other government programs, but only a very few states 
offer this provision.61 
Bethell et al50 examined the impact of one state-level policy indicator on screening rates: 
how broad the state’s eligibility criteria for Early Intervention services were. They found no 
effect of this indicator on the likelihood of having received screening. No other state level 
indicators were tested. However, the authors stated that state-level variation in screening 
prevalence was not accounted for by state differences in socioeconomic or health status of 
children. They suggested that state policy plays an important role in screening rates, and 






Godoy and Carter29 recently applied several theoretical models from the public health, 
psychology, and child development literature to the process of screening in pediatric primary 
care. These models include the Health Beliefs Model, Theory of Planned Behavior, and 
Motivational Interviewing. They focus on universal screening for social-emotional and 
behavioral concerns and hypothesize which mechanisms are involved in the identification of 
these concerns and on the decision to seek help (Figure 1). Their work has relevance to the 
current study’s focus on screening of general developmental and behavioral concerns in primary 
care settings. 
Godoy and Carter’s framework considers provider and parent factors and depicts the 
parent–provider interaction as key in the identification and referral process. Models of help-
seeking for children suggest that parents must first recognize that a behavior is of concern and 
then decide to seek help, create a plan, and take action. A parent’s cognitive appraisals will 
determine whether he or she is motivated to act. These appraisals include perceptions of the 
susceptibility of the child, severity of the condition, and parental burden, along with norms and 
expectations for child behavior that are shaped in part by sociocultural factors. A primary care 
provider’s behavior is influenced by similar cognitive appraisals. Beyond the individual 
appraisals, disparities in access to care and quality of care are key factors influencing help-
seeking for child concerns. 
This conceptual framework includes screening of the child as a triggering event or cue to 
action that may increase the likelihood of the parent recognizing a problem and then seeking 
help. The screening can influence the parent and provider appraisal process and enhance the 




to a conversation about developmental and behavioral concerns and, therefore, feel more 
comfortable raising their concerns. Alternatively, the screening could alter their perceptions of 
the child’s behavior. 
Godoy and Carter discuss the importance of provider education and cultural competency 
in conducting screening. Provider biases and lack of understanding of sociocultural factors 
affecting parent beliefs may influence screening and follow-up. The Godoy and Carter 
framework does not include factors that influence whether or not a screening is administered, 
including the broader policy-level factors that influence this process. The current dissertation 
aims to extend their conceptual framework by better understanding variations in DBS rates, 





Figure 1. Influences on Parent Help Seeking and Provider Recommendations (Godoy & Carter, 2013) 
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CONTRIBUTIONS OF THIS STUDY 
This study examines the socio-demographic, health care, and state-level policy factors 
associated with DBS and DBM among young children. It builds on earlier work by Bethell et al50 
that examined state variations in 2007 DBS rates and found evidence that state policy plays a 
role in DBS rates; they recommended further research on the impact of state policy choices on 
screening. It also considers the Godoy and Carter framework and which factors are associated 
with DBS.  
The National Survey of Children’s Health (NSCH) is the only national dataset with 
estimates of DBS rates. These data are used to track progress towards Healthy People 2020 goals 
and to measure HRSA National Performance Measures and NQF indicators. Nevertheless, we 
found very little published research on DBS using the 2011/2012 NSCH dataset. There is one 
peer-reviewed article by Barger and colleagues72 that was published in July 2017 and two 
unpublished online analyses, one by the Data Resource Center that hosts the NSCH interactive 
data portal51 and one by Child Trends.73 
The Data Resource Center online portal showed that, in 2011/12, children who were not 
White and children whose families were below 200% of the FPL had lower developmental 
monitoring rates but not lower screening rates than White children and non-poor children. 
The Child Trends analysis focused on predictors of risk for developmental delays. The 
brief report mentioned that developmental screenings did not differ by gender, race/ethnicity, 
poverty level, or parental education. No study methods were reported, so it is not clear what 
types of analyses were conducted to reach that conclusion. 
Barger and colleagues mapped state differences in screening rates from 2007 to 2011/12. 




increased significantly, but rates for Black children did not. However, their study did not 
compare Hispanic children from English-speaking homes to Hispanic children from non-English 
speaking homes, and said little about policy. The study also did not include the NSCH’s full 
measure of DBS, and used only the first question in the DBS survey item. The validated version 
of the DBS item (which is used in the current study) includes three questions. 
Therefore, there is currently very little literature on national patterns in receipt of DBS 
and DBM using the 2011/12 NSCH. This study adds to the literature in four key ways. First, we 
explore the differences between receipt of DBM and DBS in more detail than previously. While 
professional guidelines recommend both DBM and DBS as key preventive health services, the 
authors found no previous studies exploring population-level DBM rates in comparison to DBS 
rates. A study by Rice et al6 using the 2007 NSCH presented the national DBM rate as compared 
to DBS rate, but did not report on variations in DBM rates across child populations or across 
states. Second, we explore whether racial disparities exist in receipt of DBM and DBS. We aim 
to increase understanding of whether DBS may be particularly helpful for the identification of 
developmental concerns among racial/ethnic minorities who have been less likely to have their 
developmental concerns identified. This might occur if DBS is equitably administered across 
racial groups as compared with DBM. Research suggests there are disparities in identification of 
problems by race/ethnicity. This study examines whether DBS may be considered a tool to close 
that gap and to ensure more Black and Latino children are identified, as was suggested by Brown 
and Wissow.30 Third, we investigate the influence of state policy factors on receipt of parent-
reported DBS in 2011/12. The study focuses on Medicaid policy because of the 
disproportionality of developmental and behavioral problems among poorer children and the 




within a conceptual framework29 that examines screening in a pediatric setting. This study 
extends the framework to consider the socio-demographic, health care, and policy factors that are 
associated with the receipt of DBS. If DBS is a potential catalyst to help-seeking, then disparities 
in who receives screening is an important public health issue. 
This study can inform policy and practice recommendations to increase DBS, with the 
public health goals of early identification of, and intervention for, young children’s 




Aim 1: Describe rates, across subgroups of children, of (i) Developmental and 
Behavioral Screening (DBS) and (ii) Developmental and Behavioral Monitoring (DBM). 
Aim 2: Estimate the association between race/ethnicity and (i) DBS and (ii) DBM to 
determine whether there are racial disparities in DBS and DBM receipt. 
Aim 3: Describe the variation in DBS and DBM rates across states and identify state-




CHAPTER 2: METHODOLOGY 
 
STUDY DESIGN 
We used multiple logistic regression methods to conduct a secondary data analysis of the 
cross-sectional National Survey of Children’s Health (NSCH), fielded in the United States in 
2011/2012. We evaluated socio-demographic, health care, and policy factors associated with 
young children’s receipt of two preventive health care services, recommended by the American 
Academy of Pediatrics and considered best practices in pediatric care: (1) DBS and (2) DBM. 
DBS involves a health care provider requesting a parent to complete a standardized, validated 
questionnaire about the child’s development and behavior. In contrast, DBM involves a health 
care provider observing the child and asking a parent if she/he has concerns about the child’s 
development, behavior or learning but not using a standardized tool. We assessed variability in 
the receipt of DBS and DBM across racial groups. We then examined state-level variations in 
DBS and linked two state-level policy factors from a 2011 National Academy for State Health 
Policy survey to the NSCH dataset for an analysis of their impact on DBS rates at the state level. 
A path diagram is presented in Figure 2 and delineates variables that were included in the 
statistical models. These variables were divided into 3 categories: socio-demographic, health 
care access, and developmental risk. Variables were selected based on factors included in the 
Godoy and Carter framework as well as the specific focus of the current study, including state-
level policy. The dataset included two levels of data: level 1 was household/child and level 2 was 









Description: Overview of variables and their relation with each other for the analyses that follow. 





We used two data sources: the National Survey of Children’s Health for DBS and DBM 
data at the child and state level and a survey from the National Academy for State Health Policy 
on Medicaid policy at the state level. 
National Survey of Children’s Health (NSCH) 
There is no national database that routinely captures the number of young children 
screened or monitored in primary care.39 Health care providers are not required to systematically 
report this information. The only reliable source of DBS and DBM data is the NSCH, a 
nationally representative parent-completed survey.74 This survey produces the only dataset that 
offers national and state level estimates of the occurrence of DBS and DBM among young 
children.50 
The NSCH is a cross-sectional national telephone survey of households with at least one 
child age birth to 17 years and is funded by the Maternal and Child Health Bureau within the 
U.S. Department of Health and Human Services. The National Center for Health Statistics 
(NCHS) of the Centers for Disease Control (CDC) oversees sampling and interviewing. The 
NSCH is designed to estimate national and state-level prevalence for several child health and 
wellbeing indicators and produce information to guide policymakers. The survey was conducted 
by telephone in English, Spanish, and Asian languages in 2003/2004, 2007, and 2011/2012. The 
NSCH was then redesigned and combined with an allied survey, the National Survey for 
Children with Special Healthcare Needs. The new survey was fielded in 2016.  
NSCH 2011/12 sampling and data collection75 utilized the State and Local Area 
Integrated Telephone Survey (SLAITS) developed by the NCHS that produces data that are 





The NSCH aimed to select a sample of households that would result in 1,800 completed 
interviews in each state and Washington, D.C. The target for landlines was 1,200 and for 
cellphones was 600. 
A random sample of all possible landlines and cellphones in each state and Washington, 
D.C. was selected for screening. These numbers were called.  The person answering the call was 
asked whether there were one or more children aged birth to 17 years living in the household. If 
the answer was yes, the interviewer asked the ages of all children living in the household. If 
more than one age-eligible child was in the household, then one child was randomly selected to 
be the subject of the interview. If the household included only one child, then that child was the 
focus of the interview. The NSCH then identified an adult informant by asking for a parent or 
guardian who lived in the household who knew the most about the health and health care of the 
sampled child. After this person was identified, he/she was asked to give verbal consent for study 
participation and the survey questions were administered. The primary sampling unit was the 
household and the stratum variable was the state of residence of the child. 
In the 2011/2012 NSCH, informants were biological, step-, foster, or adoptive mothers 
(68.6%), biological, step-, foster, or adoptive fathers (24.2%), and other relatives or guardians 
(7.2%). 
In 2011/2012, the NCHS collected a total of 95,677 surveys nationally that included an 
average of 1,850 interviews per state (ranging from 1,811 in South Dakota to 2,200 in Texas). 
Interviews included 70 measures of child health and well-being76 with questions in the following 
sections: demographics, child’s health and functional status; health insurance coverage; health 




and adolescence (6–17 years); family functioning; parental health; and neighborhood and 
community characteristics.  
Estimates from the NSCH were adjusted for nonresponse and weighted to represent the 
population of non-institutionalized children birth to 17 years nationally and in each of the 50 
states plus the District of Columbia. 
The response rate for interviews was 23.0% overall with 38.2% for the landline sample 
and 15.5% for the cell-phone sample.77 The NCHS assigned each record a single sampling 
weight. This weight accounted for the probability of selection of each telephone number from 
among others. The weight was adjusted to account for non-response, non-residential lines, and 
sub-sampling. Then an adjustment was used to match each state’s weighted responses to 
demographic characteristics of the state’s population, based on the 2011 American Community 
Survey. The NCHS conducted a non-response bias estimate and found that those who were 
interviewed were more likely to live in rural, less dense, areas and to comprise more non-
Hispanic White people. However, the adjustment to the weights reduced the potential bias to 
very low levels.78 
Although the respondents to the survey were parents or guardians, the results were 
weighted to reflect the population of children ages birth to 17, not parents or families. Results 
must therefore be reported in terms of children, even if the question asks about parents. For 
example, when reporting on parent concerns about a child, the appropriate conclusion is: 
“percentage of children whose parent reported one or more concerns” rather than “percentage of 
parents who reported one or more concerns.” 
We obtained the publicly available NSCH dataset from the Data Resource Center for 




(CAHMI), a national program based at the Bloomberg School of Public Health at Johns Hopkins 
University in Baltimore, Maryland (see www.childhealthdata.org.). CAHMI makes the NSCH 
dataset available to researchers. We submitted a request and received the dataset electronically, 
in a version suitable for analysis using Stata 14.2 software. 
National Academy for State Health Policy (NASHP) 
In 2011, NASHP distributed a survey to all state coordinators of the Early Periodic 
Screening, Diagnosis, and Treatment (EPSDT) program, which is the child health component of 
Medicaid required in every state to finance pediatric services.79 The survey included the 
following two questions: 
• Does your state Medicaid program require standardized developmental screening 
as part of well-child exams? 
• Does your state Medicaid program pay an additional fee beyond the usual well 
childcare reimbursement for standardized developmental screening? 
State Medicaid personnel in 39 states and the District of Columbia completed this survey 
(78% response rate). States that did not submit responses were: Florida, Hawaii, Maryland, 
Missouri, Mississippi, North Dakota, New Hampshire, New Jersey, South Carolina, Wisconsin 
and West Virginia. 
 
STUDY POPULATION 
The study population consists of children age 5 years and under living in the United 
States. In the NSCH, the DBS items were asked of parents of children 10 months to 71 months of 
age; however, the publicly available dataset does not provide an age variable by month. We had 




months and decided on the former so as to include data for children 10 and 11 months and to be 
consistent with the way CAHMI reports on these data. 
The study restricts analyses to children who received at least one health care visit in the 
12 months before the survey as the DBS and DBM questions were only asked of this group 
(91.4% of the total population of children birth to 71 months of age). This was to ensure that 
children had had the opportunity to be screened or monitored by a health care provider. Receipt 
of a health care visit was based on parent reports of whether the child saw a doctor, nurse, or 
other health care professional for any kind of medical care in the past 12 months, including sick-
child care, well-child checkups, physical exams, and hospitalizations. 
 
STUDY VARIABLES 
The following variables were included in the study: outcome measures, covariates, and 
state-level policy variables. 
Outcome Measures 
Receipt of DBS: 
We considered a child to have received a DBS if the survey respondent answered 
affirmatively to three NSCH survey items that focused on a child’s receipt of a physician-ordered 
parent-completed standardized screening tool (see Figure 3). The items enquired whether a 
doctor or other health care provider asked the parent/respondent to complete a questionnaire 
about concerns or observations they had about their child’s development, communication or 
social behaviors in the previous 12 months. If the respondent answered in the affirmative, the 
respondent was asked whether the questionnaire included age-related specific questions about 




answered “yes” to question 1 and “yes” to each of the age-specific follow-up items. This is the 
scoring method used by the developer of the survey items.51 
Figure 3. DBS Questions in NSCH 2011/12 
The DBS questions were developed by CAHMI. They were field tested in English and 
Spanish and refined through cognitive interviews with parents of young children (N=36) who 
received services in pediatric practices that used or did not use standardized, parent-completed 
developmental and behavioral screening tools.50 Field testing of the questions revealed no false-
negatives in that all children who met criteria for having a DBS were confirmed to have 
completed a standardized screening questionnaire. There were a small proportion of false-
positives, suggesting that the DBS measure may slightly overestimate the prevalence of DBS. 
Receipt of DBM: 
The DBS items were preceded on the NSCH by one question enquiring whether a health 
care provider had asked the parent if she/he had concerns about the child’s learning, 
development or behavior. We coded questions answered in the affirmative as “yes” to DBM (see 
Figure 4). 
Introduction: Sometimes a child's doctor or other health care providers will ask a parent to fill out a 
questionnaire at home or during their child's visit. 
1. During the past 12 months, did a doctor or other health care provider have you fill out a 
questionnaire about specific concerns or observations you may have about [CHILD]’s 
development, communication, or social behaviors? (ages 10–71 months) 
1a. Did this questionnaire ask about your concern or observations about how [CHILD] 
talks or makes speech sounds? (ages 10–23 months) 
1b. Did this questionnaire ask you about how [CHILD] interacts with you or others? (ages 
10-23 months) 
1c. Did this questionnaire ask about your concern or observations about words and 
phrases [CHILD] uses and understands? (ages 24–71 months) 
1d. Did this questionnaire ask about your concern or observations about how [CHILD] 




Figure 4. DBM question in NSCH 2011/12 
Covariates 
Covariates were categorized into three groups: socio-demographic factors, health care 
access factors, and developmental risk factors. Socio-demographic factors included child age, 
child sex, race, ethnicity, language, maternal educational level, and family income; health care 
access factors included insurance type, usual place for care, personal doctor, and medical home 
status; and developmental risk factors included parent concerns and whether the child had a 
special health care need. The following sections give an overview of the variables within each 
category. 
Socio-Demographic Factors: 
Child age: For Aim 1 (Table 1), the age variable was categorized as 0–23 months; 24–35 
months; and 36–71 months. For Aims 2 and 3 (Tables 2 and 3), we used two age categories: 0–
35 months and 36–71 months. 
Child sex: “Male” and “female” were the two categories available in the NSCH. 
Race, Ethnicity, and Primary Language Spoken in the Home: The variables for race, 
ethnicity, and primary language were combined and coded as follows: 
• non-Hispanic White 
• non-Hispanic Black 
• Hispanic English speaking 
• Hispanic non-English speaking 
During the past 12 months / Since [CHILD]’s birth], did [CHILD]’s doctors or other 
health care providers ask if you have concerns about [his/her] learning, development, or 





This combination and coding were derived from questions asking firstly whether the 
child was of Hispanic, Latino, or Spanish origin. Questions were then asked about racial 
designations as follows: 
• “White” 
• “Black” or African-American 
• “American Indian” 
• “Alaska Native” 
• “Asian, Native Hawaiian, or other Pacific Islander” 
The language question asked: “What is the primary language spoken in your home?” Of 
the 19% of children 5 years and under living in households with a non-English language as the 
primary language, approximately three-quarters lived in a Spanish-speaking household. The 
remaining children were in households where another non-English language was spoken.77 To 
protect confidentiality, the specific language spoken was suppressed. 
Family income: Socio-economic status was based on questions about total combined 
family income during last calendar year for all members of the family before taxes, including 
money from jobs, social security, public assistance, etc. This was coded into 4 categories relating 
to the DHHS federal poverty level (FPL): 0–99% FPL; 100–199% FPL; 200–399% FPL; and 
400% FPL and greater. 
Mother’s educational level: This was coded as below high school, high school, and 




Health Care Access 
Insurance Type: Questions asked whether the child had any kind of health care coverage 
including health insurance, prepaid plans such as HMOs, or government plans such as Medicaid. 
The next question asked if the coverage/insurance was Medicaid or the Children’s Health 
Insurance Program, CHIP. Insurance type was coded as Public Insurance, Private Insurance, or 
Uninsured. 
Usual Place for Care: The question asked if there was a place the child usually went to 
when he/she was sick or if the parent needed advice. Responses included “No,” “Yes, one 
place,” and “Yes, more than one place.” For this study, responses were dichotomized into “Yes” 
or “No.” 
Personal Doctor: The question asked if there were one or more persons the parent 
thought of as child’s personal doctor or nurse (“health professional who knows your child well 
and is familiar with your child’s health history”). Responses included “No,” “Yes, one person,” 
and “Yes, more than one person.” For this study, responses were dichotomized into “Yes” or 
“No.” 
Medical Home: This was a composite measure defined on the basis of responses to 10 
survey items in five component variables.80 The measure was first included in the 2001 National 
Survey of Children with Special Health Care needs and refined in subsequent surveys. A medical 
home refers to an approach to medical care for children (not a place) that is accessible, 
continuous, comprehensive, family-centered, coordinated, compassionate, and culturally 
effective. The concept was first defined by the AAP in 1992 and revised in 2002. The medical 
home approach is a priority for child health policy, is in HP2020 goals and in the goals of 




nurse, a usual source for sick and well care, family-centered care, problems getting referrals (if 
needed), and effective care coordination (if needed). Family-centered care included whether 
parents were satisfied with the communication among child’s health care providers and other 
providers, whether they felt that health care providers spent enough time with them, listened 
carefully to them, were sensitive to the family’s values and customs, gave the specific 
information they needed, and helped parents feel like a partner in the child’s care. 
To qualify as having a medical home, children had a personal doctor, a usual source of 
care, and family-centered care. They also received needed referrals or care coordination. For this 
study, the variable was categorized as dichotomous (children whose health care met medical 
home criteria; children whose health care did not meet medical home criteria). 
Developmental Risk 
Parent Concerns: The NSCH included the research version of the Parent’s Evaluation of 
Developmental Status (PEDS), a child development screening test developed by Frances Page 
Glascoe.81 The first question in the series of 9 asked if the parent had any concerns about the 
child’s learning, development, or behavior (yes/no). The questions that followed asked about the 
extent to which the parent was concerned (a lot, a little, or not at all) about several specific areas, 
depending on age and relating to speech, understanding, motor functions, behavior and social 
relationships, and learning. This study used a derived variable for children who had parents with 
one or more concerns about the child’s learning, development or behavior. It was derived from a 





Figure 5. Parents’ Evaluation of Developmental Status (PEDS) Questions in NSCH 2011/12 
 
Child with Special Health Care Needs (CSHCN): This was a composite measure that 
followed the federal Maternal and Child Health Bureau’s definition of children with special 
health care needs as “those who have or are at increased risk for a chronic physical, 
developmental, behavioral, or emotional condition and who also require health and related 
services of a type or amount beyond that required by children generally” (except that it excluded 
the “at risk” group so as to focus on current CSHCN). There were five CSHCN survey items that 
focused on the health consequences a child experiences due to an ongoing health condition.82 
They asked whether the child used more services than typical for her age, was limited in her 
ability to do things, or got special therapies for a health condition that had lasted or was expected 
to last more than 12 months. These items were developed and validated by CAHMI on large 
population samples totaling 23,000 children.83 
Do you have any concerns about [CHILD'S NAME]'s learning, development, or behavior?  
Are you concerned about how [he/she]: (a lot, a little or not at all) 
a. Talks and makes speech sounds? (ages 4 months–5 years) 
b. Understands what you say? (ages 4 months–5 years) 
c. Uses [his/her] hands and fingers to do things? (ages 4 months–5 years) 
d. Uses [his/her] arms and legs? (ages 4 months–5 years) 
e. Behaves? (ages 4 months–5 years) 
f. Gets along with others? (ages 4 months–5 years) 
g. Is learning to do things for [himself/herself]? (ages 10 months–5 years) 




State Level Policy Variables (NASHP survey) 
Medicaid Policy 
State level variables included 2 questions on a survey: 
• Does your state Medicaid program require standardized developmental 
screening as part of well-child exams? 
• Does your state Medicaid program pay an additional fee beyond the usual 
well childcare reimbursement for standardized developmental screening? 
Responses were categorized as follows: 
• State Medicaid program required standardized developmental screening as 
part of well-child exams and paid an additional fee beyond the usual well-
child care reimbursement for this screening 
• State Medicaid program required standardized developmental screening as 
part of well-child exams but did not pay an additional fee beyond the usual 
well-child care reimbursement for this screening 
• State Medicaid program paid an additional fee beyond the usual well-child 
care reimbursement for standardized developmental screening but did not 
require this screening as part of well-child exams 
• State Medicaid program did not require standardized developmental 
screening as part of well-child exams and did not pay an additional fee 
beyond the usual well-child care reimbursement for this screening 






During the NSCH, precautions were taken to protect the privacy and confidentiality of 
parents/caregivers who responded to the survey. All NSCH study procedures were approved by 
the National Center for Health Statistics’ Research Ethics Review Board and the NORC 
Institutional Review Board at the University of Chicago and cleared by the federal Office of 
Management and Budget. Only adults over age 18 were interviewed. The respondent was 
informed of his or her rights as a survey participant, including voluntary participation, and 
confidentiality of identifiable information. Verbal consent was obtained and documented in the 
computer system. 
The current study, as a secondary data analysis, received an exempt status from the 
Institutional Review Board of the City University of New York. The principal author was 
certified in ethical research practices through the Collaborative Institutional Training Initiative 
(CITI). The author signed a data use agreement with the DRC and the dataset was handled in 
accordance with this agreement. Data were de-identified. 
 
ANALYTIC PLAN 
Adjustments for Survey Design 
Complex survey designs have unequal probabilities of selecting clusters and/or people 
within clusters. For example, in a child health survey, children in smaller states and children in 
smaller families have a greater probability of selection.84 Therefore, when analyzing a survey 
with a complex sampling design, it is necessary to include the sampling design weights to 
account for unequal probability of sample selection.84 Statistical analyses of the NSCH for this 




To estimate complex sample variances, the data files provided the stratum identifier 
which was a state identifier with the variable “state,” and the primary sampling unit (PSU), 
which was a unique household identifier.77 As specified by the survey developers, we created a 
new variable to account for the landline sample and cell-phone sample, called “statesamp” 
(statesamp=state*sample).  We pre-specified the clusters and strata before analyses were 
conducted in order to account for the sampling designii. Therefore, statesamp was the strata 
variable and specified the mode of survey administration (cell or landline) together with the 
Level 2 variable “state” (state of residence). In addition, we included the variable “state” in all 
regression analyses as the stratum identifier so as to control for the effect of the child’s state of 
residence. 
This study examined a specific population subgroup, children birth to 71 months. The 
dataset was not subsetted to delete records of children of other ages as subsetting to specific 
population subgroups in a dataset from a complex survey design could result in incorrect 
standard errors. Therefore, the Stata “if” command was used to analyze the specific age group. 
Variables were tested for collinearity using a correlation matrix. There were two notable 
findings—family income and insurance type were correlated (r=0.54); family income and 
mother’s education were correlated (r=0.50). 
Analytic Procedures 
First, exploratory analyses were conducted to understand the qualities of study variables, 
including frequencies and distributions. Next, bivariate analyses were conducted to assess 
relationships between variables and to verify patterns among variables. Variables were examined 
                                                 




for missingness. All variables used in the study from the NSCH had less than 7% missing data. 
We excluded missing data from the analyses. Missing data included the following types of 
data—not in universe (i.e., skipped on the basis of eligibility criteria); legitimate skip due to 
valid questionnaire paths; partially completed interview; missing in error due to interviewer or 
system errors. In the data file, missing data due to a respondent not knowing the answer or 
refusing to provide the answer were not assigned a missing value but rather a numeric code 
(e.g., 6, 96, 996 for unknown and 7, 97, 997 for refused). We recoded all data that were unknown 
or refused as missing and, as specified in survey documentation for the publicly available 
dataset, did not include them in the denominator when calculating estimates. 
Next, we generated descriptive statistics for child characteristics by calculating weighted 
frequencies/percents and 95% confidence intervals. Then, we calculated DBS rates and DBM 
rates across subgroups of children by socio-demographic factors, health care access indicators, 
and developmental risk. We then conducted Pearson’s chi-squared tests to assess whether there 
were statistically significant differences in DBS receipt across these subgroups of children, for 
example males versus females. We then compared 2011/2012 DBS data with 2007 NSCH data 
that were available on the CAHMI web portal and also published in Bethell et al.50 
We fit multiple logistic regressioniii models that evaluated the association between the 
dependent variable (receipt of DBS or receipt of DBM) and the independent variables. We 
selected the variables on the basis of their conceptual link to the dependent variable based on 
past literature and the conceptual framework of Godoy and Carter (Figure 1). 
                                                 
iiiLogistic regression assesses the odds or probability of a dichotomous outcome as a 
function of a risk factor and covariates, specifically how much an increment in a given 




Next, we calculated DBS rates and DBM rates for each of the 50 states and the District of 
Columbia. We used nested t-tests to assess differences in state prevalence of DBS. We conducted 
the same analyses on the DBM variable. We fit regression models to include two policy factors. 
These models evaluated whether variations in the two state policies were associated with 
increased or decreased odds of DBS. 
We conducted all analyses using Stata statistical software (Version 14.2) and commands 
appropriate for the survey design. This statistical software has the capacity to account for the 
complex sampling design of the NSCH. Before coding, we pre-specified the dataset clusters and 
strata. 
Due to the nested design of the NSCH (households within states), multilevel modeling 
techniques (MLM) are appropriate in that they simultaneously test the effects of group-level and 
individual-level variables on individual-level outcomes.85 MLM accounts for the clustered nature 
of the data and also examines sources of variation within and across clusters. The technique is 
particularly relevant for public health policy in that it acknowledges the association between 
individuals and their context by considering individual characteristics as well as characteristics at 
other levels of analysis, such as state (or school or neighborhood).86 Multilevel models account 
for the hierarchical data that are derived from cross-sectional studies of individuals clustered in 
groups (such as the NSCH data) or from longitudinal studies with data from different time points 
correlated with each other. 
For the purposes of this study, each regression model included the Level 2 variable 
“state”. Due to the limitations of using Stata for survey datasets, we decidediv to double the 
                                                 
iv As advised by Alexis Pozen, Ph.D. and William T. Gallo, Ph.D., MBA, faculty in the 




standard errors in each regression output, to determine significance. This was done because 
traditional regression approaches with hierarchical nested data can lead to incorrect standard 
errors and therefore biased inferences about the significance of the regression coefficients.85 
Confidence intervals were calculated from these revised standard errors using the 
equation: 
(𝒆𝑳, 𝒆𝑼) 
Where,    𝑳 = ?̂? − 𝒕 ∗ 𝑺𝑬?̂? 
𝑼 = ?̂? + 𝒕 ∗  𝑺𝑬?̂? 
and t is the value from the standard t-distribution for the selected confidence level (depending 
on the degrees of freedom). In the current study, models were fit to answer the following 
questions: 
1. Does DBS/DBM vary across states? No predictors are included; examines whether average 
DBS/DBM prevalence varies across states. 
2. Is race/ethnicity associated with DBS/DBM and does that relationship differ across states? 
(Level 1 only) 
3. Does a state-level DBS policy influence DBS? (Level 2 only) 
These models did not test for Level 1 (household/child) and Level 2 (state of residence) 
interactions. Future analyses will use Median Odds Ratios (MOR) to evaluate the variance within 
and across states that is unaccounted for by predictors i.e. cross-level interactions (between 
individual and state)110. 
 
Analytic Plan for Specific Aims 




We produced descriptive statistics to show the characteristics (socio-demographic, health 
care access, and developmental risk) of the study population. Next, we analyzed DBS and DBM 
rates for each subgroup. Chi-squared tests examined the significance of variations in DBS and 
DBM rates within these subgroups. We compared NSCH 2011/12 data with NSCH 2007 data 
available on the CAHMI web portal and reported by Bethell et al50, 87 and examined changes in 
DBS and DBM rates over that time period. 
Aim 2. Estimate the association between race/ethnicity and DBS. Estimate the association 
between race/ethnicity and DBM. Then use these estimations to determine whether there are 
racial disparities in DBS and DBM receipt. 
The bivariate (unadjusted) association between DBS and race/ethnicity was assessed. 
Then a multivariable logistic regression model examined the adjusted association between the 
outcome (DBS) and race/ethnicity while controlling for age, sex, income, insurance type, 
medical home, parent concerns, special health care need, and state of residence. This was 
repeated for DBM. 
Plan for Aim 3: Describe the variation of DBS and DBM rates across states. Identify 
state-level policy factors that may influence DBS rates. 
We examined the variation in DBS rates and DBM rates across states by t-test. 
Thereafter, a multivariable logistic regression model assessed the relationship between the 
outcome (DBS) and state policy while controlling for child-level factors (race, sex, income, 
insurance type, medical home, and parent concerns).  
This examined whether children who lived in a state with a Medicaid requirement and 
additional reimbursement for DBS were more likely to receive a DBS. The analysis included the 




other sources of information on state-specific policies to identify potential policy factors that 




CHAPTER 3: RESULTS AND INTERPRETATION 
 
STUDY POPULATION 
This study’s population consisted of children from birth to 71 months who had received 
at least one health care visit in the previous 12 months—almost 28,000 children representing 
approximately 22.02 million children in the United States (Tables 4–6). Children 0–35 months 
were 48.6% and children 36–71 months were 51.4% of the population. Almost all the socio-
demographics, health care access, and developmental risk of the study population were similar to 
the entire population of children birth to 71 months in the United States at the time of the NSCH 
implementation in 2011/2012 (N=29,975 representing approximately 24.12 million children). 
This study’s population had slightly fewer children with household incomes of 0%–99% FPL 
and slightly more children with household incomes of 400% FPL or greater; as well as slightly 
more children on private insurance and fewer who were uninsured.  
RACIAL AND ETHNIC DIFFERENCES IN HEALTH CARE ACCESS 
There were racial/ethnic differences in children’s type of health insurance and in their 
access to a medical home (Table 7). Nationwide, Black children and Hispanic children from non-
English speaking households were more likely to be on public insurance (67% and 80%) than 
White children (28%) or Hispanic children from English-speaking homes (46%). In contrast, 
Black children and Hispanic children from non English-speaking homes (30% and 12%) were 
less likely to be on private insurance than White children (68%) or Hispanic children from 
English-speaking homes (47%). There were also racial/ethnic differences related to children’s 




49% of Black children, 55% of Hispanic children in English-speaking homes, and 31% of 
Hispanic children from non-English speaking homes were in medical homes. 
 
RATES OF SCREENING AND MONITORING (AIM 1) 
Receipt of Screening 
Nationally, fewer than one in three children under 71 months (30.8%) received a DBS 
from their health care provider in the prior year, of those children who had a health care visit 
during that time. DBS rate was calculated by age, sex, race/ethnicity, family income, mother’s 
education, type of health insurance, access to a personal doctor, a usual source of care or medical 
home, parental concerns, and special health care need status (Tables 8-10). The DBS rate was 
highest for children 0–35 months (38.0%). No other group had a DBS rate higher than this. 
Chi-squared tests examined the significance of variations in DBS rate within these 
subgroups. Children under 3 years were more likely to receive a DBS than children 3–5 years 
(38.0% vs. 26.2%, p < 0.001). Children with a special health care need (CSHCN) were more 
likely to receive a DBS compared with children who did not have a special health care need 
(36.7% vs. 29.9%; p < 0.001). 
There were no statistically significant differences in receipt of DBS by sex, 
race/ethnicity, family income, mother’s education or type of health insurance, access to a usual 
place for care, access to a personal doctor, medical home status, or parent concerns. To 
investigate the lack of difference by family income, further analyses were conducted using 
different categorizations of income levels. The lack of difference across income levels held when 




comparing children at less than 100% of the FPL with children 100% and above. The lack of 
difference across racial/ethnic groups held when comparing Black vs. non-Black children. 
Importantly, children’s receipt of DBS did not differ according to whether their parents 
had concerns about their development, behavior, social relationships, or learning. In fact, 
children whose parents did not have concerns were slightly less likely to receive DBS than those 
whose parents did have concerns (29.6% vs. 31.7%) although this difference was not statistically 
significant at the p < 0.05 level. 
Receipt of Monitoring 
DBM was more frequently received than DBS, although this was still by only half the 
population (51.8%). DBM rate was calculated for each subgroup listed above (Tables 8-10). Chi-
squared tests examined the significance of variations in DBM rate within these subgroups. 
Prevalence of DBM showed more variation than DBS across several socio-demographic sub-
groups. The DBM rate was significantly higher for children birth to 35 months of age compared 
with children 36–71 months (56.0% vs. 47.9%, p < 0.001) and there were statistically significant 
differences (at the p < 0.001 level of significance) across race/ethnicity, family income and 
maternal education with highest DBM rates reported for White non-Hispanic children (58.7%), 
children with family income at 400% FPL or greater (57.9%), and children whose mothers had 
more than a high school education (56.9%). 
DBM showed significant variation on several health care access measures. DBM rates 
were higher (p < 0.001) for children on private insurance (57.6%) as compared to children on 
public insurance (46.3%) or uninsured children (38.3%). Children with access to a personal 
doctor had higher DBM rates than those without (53.2% vs. 35.2%, p < 0.001), while children 




37.8%, p < 0.01). DBM was higher for children in a patient-centered medical home (59.4% vs. 
42.1%, p < 0.001). In addition, DBM was higher for children with a special health care need than 
for those without (64.7% vs. 50.0%, p < 0.001). 
Rates of Screening and Monitoring 
More than 1 in 3 children age 5 and under (39.7%) received neither DBS nor DBM in the 
previous 12 months (Table 11). There were 8.3% of children who received DBS but no DBM, 
29.4% who received DBM but no DBS, and 23% who received both DBS and DBM. 
An analysis of the 60.3% of children who received DBS and/or DBM found that those 
children who had a medical home had higher odds of receiving either DBS or DBM than 
children who did not have a medical home (OR 1.72, p < 0.05) and children with special health 
care needs were also more likely to receive one or both of DBS and DBM (OR 1.90, p < 0.05). 
Children 36–71 months (older children from this cohort) had lower odds of receiving either DBS 
or DBM than children birth to 35 months (OR 0.59, p < 0.001) and uninsured children were also 
less likely to receive either DBS or DBM than children on public or private insurance (OR 0.60, 
p < 0.1) 
We examined the predictors of having a medical home (Table 12) and found that children 
who were under 3 years of age were borderline significantly more likely to have a medical home 
than children 3 to 5 years (OR 1.28, [0.98, 1.69], p < 0.05). Male children were borderline 
significantly less likely to have a medical home (OR 0.84 [0.70, 1.02], p < 0.05). Children who 
were not White were significantly less likely to have a medical home than White children (Black 
children: OR 0.49 [0.37, 0.64], p < 0.001; Hispanic English-speaking OR 0.57 [0.38, 0.87], 
p < 0.001; Hispanic non-English-speaking OR 0.25 [0.21, 0.30], p < 0.001; Multiracial OR 0.52 




insurance had lower odds of having a medical home (OR 0.57 [0.45, 0.72], p < 0.001) as did 
children who were uninsured (OR 0.36 [0.24, 0.54], p < 0.001). 
Changes in Screening Rates over Time 
The national DBS rate increased from 19.5% in 2007 to 30.8% in 2011/12, a 58% 
increase from 2007 (11.3 percentage points) (Table 13). 2011/12 rates were less variable than 
those in 2007. In 2007, there were significant differences in DBS across socio-demographics 
groups with significantly higher DBS rates for Black non-Hispanic children compared to White 
children, low income compared to higher income, and publicly insured compared to privately 
insured children. In contrast, in 2011/12, none of these groups had maintained their higher DBS 
prevalence as certain subgroups showed larger increases in DBS rate than others over the 5-year 
time period. 
DBS rates increased from 2007 by 68% for children under 36 months and by 51% for 
children 36–71 months. Rates increased from 2007 by 84% for Hispanic children in non-English 
speaking households, 61% for White children, and only by 30% for Black children. There were 
also larger increases in DBS over time for higher income children; those below 200% of the FPL 
increased by under 50% from 2007 rates, while children living in households with 400% FPL 
and greater had DBS rates that increased by 79% from 2007 rates. Similarly, children whose 
parents had less than a high school education saw a DBS increase of 41%, while children whose 
parents had more than high school education had a DBS increase of 63%.  From 2007 rates, 
publicly insured children increased their DBS prevalence by 33%, while privately insured 





ASSOCIATION BETWEEN RACE/ETHNICITY AND SCREENING OR MONITORING (AIM 2) 
Screening: Race and Ethnicity 
Regression analyses (Table 14) showed that Black children were not more likely to 
receive DBS than were White children, in contrast to 2007 NSCH data on DBS. This lack of 
association remained when controlling for socio-demographic, health care access, and 
developmental risk covariates. The only variable that was significantly related to DBS was age, 
with children under 3 years of age more likely to have received DBS than children 3 to 5 years 
old (OR 1.77, [1.10–2.84], p < 0.05). 
Monitoring: Race and Ethnicity 
Regression analyses (Table 15) indicated that, compared to White non-Hispanic children, 
Black children had lower odds of receiving DBM (OR 0.75 [0.59, 0.99], p < 0.05) as did 
Hispanic children from non-English speaking homes (OR 0.65 [0.47, 0.90], p < 0.05). 
Additionally, uninsured children had borderline lower odds of receiving DBM than did children 
on private insurance (OR 0.66 [0.45, 0.98], p < 0.10), while children with special health care 
needs had borderline higher odds of receiving DBM than did children without special health care 
needs (OR 2.02, [1.08, 3.79], p < 0.10). Children under 3 were more likely to receive DBM than 
were children 3–5 years old (OR 1.49 [1.05, 2.12], p < 0.05), and children with a medical home 
were more likely than children without a medical home to receive DBM (OR 1.75 [1.12, 2.74], 





VARIATION IN DBS AND DBM RATES ACROSS STATES AND POLICY FACTORS (AIM 3) 
DBS and DBM Rates across States 
In 2011/2012, DBS rates were higher, on average, than in 2007. However, there remained 
significant variations in states’ DBS rates (Table 16 and Figure 6). Nine states were significantly 
above the national average of 30.8% at the p < 0.05 level of significance (Colorado, Georgia, 
Hawaii, Massachusetts, Minnesota, North Carolina, New Mexico, Tennessee, and West 
Virginia). Eleven states (Alabama, Arizona, Florida, Indiana, Mississippi, Montana, New Jersey, 
Nevada, New York, North Dakota, and South Dakota) and the District of Columbia were 
significantly below the national average. Mississippi had the lowest prevalence at 17.5% and 
North Carolina had the highest at 58.0%. Only one other state, Massachusetts, had a DBS rate 
above 50%. 
In 2011/2012, 14 states had DBM rates significantly above the national average of 51.8% 
(Table 16 and Figure 7). These were Iowa, Kansas, Maine, Massachusetts, Minnesota, Missouri, 
New Hampshire, North Carolina, Ohio, Tennessee, Utah, Vermont, Washington, and Wisconsin. 
Four states had a DBM rate that was significantly lower than the national rate (California, 
Mississippi, New Jersey, and Texas). Mississippi had the lowest DBS rate (39.8%) and Vermont 
had the highest (66.6%). 
Increase in Screening Rates by State 
From 2007 to 2011/12, all states increased their DBS rates except for Mississippi, which 
decreased by 2.5 percentage points, from 20.0% to 17.5% (Table 17). 
Massachusetts had the largest gain of 39 percentage points, increasing from 16.4% of 




had DBS rates that more than doubled over the 4- to 5-year period (Alabama, California, 
Delaware, Massachusetts, Oregon, Pennsylvania, and Rhode Island). 
Some states’ DBS rates increased substantially over that time, but were still below the 
national mean in 2011/12. For example, New York increased from 11.7% to 21.4% (10 
percentage points), however, this remained below the national mean. 
Association between State Medicaid Policy and DBS for Children on Public Insurance 
Responses from the NASHP survey were attached to the NSCH dataset. Analyses were 
restricted to children on public insurance. Data were available from 39 states and the District of 
Columbia. 
Of the 40 states with data (Table 18), 8 states (Colorado, Indiana, Illinois, Kansas, 
Michigan, Pennsylvania, Texas, and Virginia) required DBS as part of well-child exams and paid 
an additional fee beyond the usual well childcare reimbursement for the screening. Six states 
(Georgia, Louisiana, New York, North Carolina, Rhode Island, and Wyoming) reported that they 
required screening but did not pay for it. Eighteen states (Alabama, Alaska, California, 
Connecticut, Delaware, Idaho, Indiana, Kentucky, Minnesota, Montana, Nevada, New Mexico, 
Ohio, Oklahoma, Oregon, South Dakota, Tennessee, and Vermont) reported that they paid for 
DBS but did not require it. Seven states (Arizona, Arkansas, Massachusetts, Maine, Nebraska, 
Utah, and Washington) and the District of Columbia reported neither requiring DBS nor paying 
an additional fee for it. 
For states that responded to the survey (40 states and DC), prevalence of DBS was 





• Average DBS rates for states that required DBS and paid an additional fee 
(31.9%); required DBS but did not pay an additional fee (38.2%); did not 
require DBS but did pay an additional fee (30.4%); and did neither 
(35.1%). 
• Average DBS rates for states that required or paid (32.5%) compared to 
those that neither required nor paid (35.1%) 
• Average DBS rates for states that required DBS (34.1%) compared to 
those that did not require DBS (31.4%) 
• Average DBS rates for states that paid for DBS (31.1%) compared to 
those that did not pay for DBS (37.1%). 
There were no significant differences in DBS rates across states with different policies 
when compared in these four different ways. 
Using multiple regression analysis to examine the variable for required or paid, DBS was 
not significantly more likely to be received by young children in states where the state Medicaid 




CHAPTER 4: CONCLUSIONS AND DISCUSSION 
 
SUMMARY OF FINDINGS 
Early identification of developmental and behavioral concerns is an important public 
health issue. Early identification increases the likelihood of timely intervention and positive 
developmental outcomes for young children. Primary care is an important setting for 
identification of these concerns as most young children attend well-child visits regularly and 
parents expect developmental guidance from pediatricians. Pediatric professional guidelines 
recommend that health care providers monitor children’s development (DBM) at every well-
child visit by eliciting parents’ concerns related to learning, development or behavior, taking a 
history, and observing the child. They also recommend screening all children for developmental 
delays using a standardized development and behavioral screening (DBS) tool at 9, 18, and 30 
(or 24) months. DBS and DBM are both key preventive services that, if applied consistently, 
increase the probability of detecting a developmental condition.  
Despite these guidelines, of children 5 and under who had a health care visit in the 
previous 12 months, fewer than one in three (30.8%) received a DBS at that visit. As almost 9% 
of young children did not have a health care visit, it is likely that more than 70% of all young 
children did not receive a parent-completed DBS from their health care provider. As a DBS is 
the most accurate means of identifying a developmental delay or disability, these children were 
at risk of having a developmental concern that was not identified or addressed. 
This study found that children who were under 3 years of age (0–35 months) at the time 
of the survey were more likely to have received a DBS compared with children age 3–5 years 




irrespective of socio-demographic, health care, or developmental risk indicators. Additionally, 
children’s receipt of DBS did not increase when their parents had concerns about the child’s 
development, behavior, social relationships, or learning. In fact, these children were slightly less 
likely to receive DBS than those whose parents were not concerned. This is troubling as health 
care guidelines advise that health care providers elicit and take seriously parental concerns, and 
that these concerns should trigger a DBS even if it is outside the recommended screening 
schedule.27 It is possible that a parent chose not to complete a screening because the child had a 
developmental concern that the parent already knew about. However, this may still be 
problematic in that it is important to administer repeat screenings to children with identified 
problems in order to track developmental status over time. 
Overall, it is promising that the overall DBS rate increased from 19.5% in 2007 to 30.8% 
in 2011/12. However, there is much work to be done to ensure all children are screened as 
recommended. 
Nationally, in 2011/12, developmental and behavioral monitoring (DBM) was received 
by 51.8% of children 5 and under. Although this is a considerably higher rate than the DBS rate 
of 30.8% and indicates health care providers were more likely to monitor than screen, it is still 
inadequate considering that DBM is recommended for all children at every well-child visit. 
Additionally, research has convincingly shown29,42-44 that DBM is a less reliable means of 
identifying children with developmental concerns when compared with DBS; therefore, relying 
on DBM would likely under-identify children with developmental challenges and reduce their 
chances of receiving interventions at an early stage when they are most effective. It is also 
concerning that 40% of children 5 and under received neither DBM nor DBS, making them 




In contrast to DBS, there were significant variations in DBM rates across socio-
demographic and health care access factors. Study findings suggest that providers applied 
DBM—a recommended standard of care—unevenly across their patient population. 
Compared to White non-Hispanic children, Black children as well as Hispanic children 
from non-English speaking homes had lower odds of receiving DBM. Uninsured children had 
borderline lower odds of receiving DBM than did children on private insurance. In addition, 
children who did not have a medical home were less likely to receive DBM from their health 
care provider than children who had a medical home.  Children 3-5 years of age were also less 
likely to receive DBM than were children under 3 years.   
The one finding that was consistent across DBS and DBM was that preschool age 
children were less likely to receive these preventive services than children under 3 years of age. 
This may be understandable for DBS in that professional guidelines recommend universal DBS 
up to age 30 months. However, the DBM finding suggests providers were not following 
professional guidelines that recommend all children receive regular DBM and subsequent DBS if 
a concern is identified. Provider practice with preschoolers should be further explored as it is 
particularly important to identify and remediate developmental problems before kindergarten 
entry.  
In addition to having lower odds of receiving DBM, Black children and Hispanic children 
from non-English speaking homes (49% and 31%) were also significantly less likely than White 
children (71%) to have a medical home. In addition, children on public insurance and children 
who were uninsured were less likely to have a medical home. This finding indicates these groups 




sensitive. In particular, family-centered care signifies that a provider spends sufficient time with 
a parent, listens and communicates well, and partners with the parent in the child’s care.  
 
RACIAL AND ETHNIC DISPARITIES 
Previous research has shown that children who are Black or Latino and children living in 
poverty are more likely to have a developmental and behavioral condition but less likely to have 
that condition identified.6,9,10,88 One of the ways that screening is beneficial is that it offers 
primary care providers access to parent-reported information without having to elicit concerns 
directly from parents or relying on parents to bring up their concerns. Therefore, universal DBS, 
wherein all children receive a standardized screening too (that does not rely on the provider 
asking the parent about their concerns), could be a means to reduce racial/ethnic disparities in 
identification and remediation of developmental and behavioral concerns,29,30 provided that DBS 
is offered equitably to children from all racial/ethnic and socio-economic groups. 
This study found that, in 2011/12, children were equally likely to receive DBS 
irrespective of race/ethnicity, socio-economic status, and insurance type. This is a promising 
sign. However, it should be noted that in 2007, Black children had higher DBS rates than White 
children. By 2011/12, this advantage had disappeared. The same situation occurred for low-
income children and publicly insured children. In 2007, they had higher rates than high-income 
children and privately insured children. By 2011/12 their relatively higher rates had been lost. An 
examination of changes in DBS rates over the 5-year period from 2007 to 2011/12 revealed that 
the percent increase in DBS rates from 2007 was 61% for White children but only 30% for Black 
children. In addition, DBS rates increased by 79% for higher income children as compared with 




be monitored. If the trend was to continue, it could potentially lead to new disparities in access to 
DBS that would disadvantage Black, Hispanic, and low-income children who are more likely to 
have developmental disabilities, but who are historically under-identified and treated.  
It should be noted that summary data from the 2016 NSCH survey were released while 
this report was being written. These data suggest that nationally, in 2016, White children had 
higher DBS rates than Black and Latino children and privately insured children had higher rates 
than publicly insured children.89 
To ensure that Black children, Hispanic children and low-income children do not lag in 
increases in DBS over time, it would be important to implement targeted strategies to promote 
DBS for these groups. 
This study found that although, in 2011/12, there were no racial/ethnic disparities in DBS 
rates, this was not the case for DBM.  Health care providers were less likely to offer DBM to 
Black children and Hispanic children from non-English speaking homes than to White children. 
The magnitude of the results showing racial/ethnic disparities in DBM were substantial 
compared to other variations in DBM rates across groups, for example uninsured versus privately 
insured children. Lower DBM rates were also seen for low-income children, children on public 
insurance, children whose mother had a lower level of education, and children without a medical 
home.  
DBM relies on providers’ communication with parents to elicit parent concerns (in 
contrast to a screening tool that is standardized and parent-completed). Therefore, DBM 
variability could reflect differences in provider behavior relating to the race/ethnicity and socio-




Language barriers are an issue when health care providers try to elicit concerns from 
parents about their children’s development. This study showed that Hispanic children from non-
English speaking households were much less likely to receive DBM than were White children. In 
contrast, Hispanic children from English-speaking households were as likely as White children 
to receive DBM. This supports the importance of language as a predictor of DBM and the fact 
that children whose parents speak languages other than English are less likely to receive DBM 
and may be more vulnerable to having unidentified developmental and behavioral challenges. 
Further research is needed to uncover why the racial/ethnic disparity in DBM receipt 
might occur. The Godoy and Carter framework has hypothesized that health care provider 
appraisals (expectations, perceptions, motivation) as well as training and cultural sensitivity all 
play a role in the provider-parent conversation and help-seeking process. It is possible that these 
factors have an influence on whether a provider systematically asks a parent questions about 
concerns relating to the child’s development and behavior. In contrast, as discussed above, parent 
completion of a screening tool does not require provider engagement with the parent to elicit 
concerns. 
These findings suggest that primary care providers who rely on DBM - and do not also 
offer DBS to their patients - may disproportionately disadvantage children of color and children 
from homes where English is not the primary language. In this way, health care providers could 
unintentionally perpetuate racial/ethnic disparities in the identification of, and intervention for, 
developmental and behavioral challenges. 
STATE VARIATIONS IN SCREENING 
In 2011/12, states varied widely in their DBS rates, from 17.5% in Mississippi to 58% in 




Massachusetts, Minnesota, New Mexico, North Carolina, Tennessee, and West Virginia). 
Massachusetts showed the largest increase from 2007 to 2011/12 (16.4% to 55.1%). The states 
that showed the greatest increases were Alabama, California, Delaware, Massachusetts, Oregon, 
Pennsylvania, and Rhode Island. Mississippi was the only state that had a DBS rate that 
decreased from 2007 to 2011/12. 
Using a NASHP 2011 survey that was distributed to state Medicaid officials, this study 
did not find statistically significant associations between state DBS rates and two state-level 
policies (Medicaid requirement to perform DBS as part of well-child exams and Medicaid 
reimbursement of an additional fee beyond regular well childcare reimbursement). States with 
the DBS requirement had slightly higher DBS rates, but this did not reach significance. 
Unfortunately, this policy dataset was inadequate to determine associations between these state 
policies and state DBS rates. The survey questions were very broad and likely could not 
accurately reflect states’ Medicaid policies. For example, one limitation to assessing the role of 
reimbursement is that it is hard to understand the impact of this policy on providers across 
Medicaid fee-for-service and Medicaid managed-care systems. Given the limitations of the 
NASHP dataset, it is useful to look in more detail at the specific states that had the highest DBS 
rates in 2011/12 or that had the highest increases from 2007 to 2011/12 to learn what policy 
factors may have played a role. In 2011/12, North Carolina had the highest rate (58.0%) and 
Massachusetts was second (55.1%) followed by Colorado (47.0%), Minnesota (43.8%), and 
Georgia (40.8%). In terms of increases in DBS rates from 2007, Massachusetts’ rate increased by 
236%, Delaware by 183%, and Pennsylvania by 179%. Georgia’s rate increased by 80%. 
In past studies, providers have reported several reasons for not using DBS in their 




staff time to administer the tools, and electronic and administrative systems to support the 
screening), lack of trainings, and limited availability of referral options if a concern is 
identified.90 States have at their disposal several policy levers to reduce barriers to DBS use91.  
Medicaid reimbursement policies include the amount paid for the screening and the 
requirements that providers must meet to receive payment. States can reimburse separately for 
DBS on a fee-for-service (FFS) basis or bundle the DBS payment within the well-child visit 
payment by paying an additional amount above the standard rate to providers who conduct DBS. 
States also set the specific reimbursement rate. State Medicaid agencies may choose to increase 
reimbursement rates in order to incentivize DBS.  (As of February 2016, state reimbursement 
rates for DBS (procedure code: 96110) ranged from approximately $5.00 to $60.00.91) Another 
financial lever is for state Medicaid agencies to include financial incentives in their contracts 
with managed-care organizations, for example, rewarding plans (through value-based 
purchasing) if they meet performance targets for DBS. In addition, managed-care organizations 
are required to conduct performance improvement projects and can use those projects to require 
providers in their networks to increase DBS. Managed care companies may also choose to follow 
the Medicaid fee-for-service reimbursement rate when paying their providers. 
There are several types of mandates that are used to ensure that health care providers 
provide DBS. These include a legislative mandate, where a state legislates that DBS must be 
performed; a judicial mandate, where a court enforces DBS by providers; and a regulatory 
mandate, where Medicaid agencies or Medicaid managed-care companies require DBS to be 
performed. 
There are various tools to support practice improvement including training, technical 




workshops, learning collaboratives, and web-based modules. Trainings are aided by the 
integration of screening tools into electronic medical records and by the offer of continuing 
medical education credits. Resources include educational materials such as brochures, 
newsletters, posters, and toolkits. 
States use data tracking and reporting as an incentive to increase DBS rates with the 
understanding that “what gets measured gets done.” State Medicaid agencies can require that 
providers use a procedure code (e.g., 96110) in order to track DBS rates. In addition, states can 
require managed-care companies to report their DBS rates for children on Medicaid managed-
care plans. 
States can engage in collaborative public–private initiatives aimed at increasing DBS. 
One such example is the Assuring Better Child Health and Development Initiative (ABCD). 
ABCD was formed in 2000 to support young children’s healthy development by working with 
states to improve the identification and treatment of children at risk for developmental delays. 
Another example is the Help Me Grow program that promotes cross-sector collaboration to 
create effective early childhood systems. The Help Me Grow model includes a centralized phone 
line and an intake system to refer children to appropriate services after positive screens, 
community education around development, provider outreach to support early detection, and 
data collection through linked medical and early intervention data systems.72 
 
USE OF STATE POLICY LEVERS TO INCREASE DBS RATES 
In the current study, 16 states are considered to be ‘high performers’, in that they either 
had DBS rates above the national average or had DBS rates that more than doubled from 2007 to 




Eleven of these states and the District of Columbia chose to be part of one or both of the 
ABCD or Help Me Grow initiatives. These were: Alabama (ABCD; Help Me Grow); California 
(ABCD; Help Me Grow); Colorado (ABCD; Help Me Grow); Delaware (ABCD; Help Me 
Grow); Massachusetts (Help me Grow); Minnesota (ABCD; Help Me Grow); New Mexico 
(ABCD); North Carolina (ABCD); Oregon (ABCD; Help Me Grow); Washington, DC (ABCD; 
Help Me Grow); West Virginia (Help Me Grow). Georgia, Pennsylvania, Rhode Island, Hawaii, 
and Tennessee did not implement either one of these programs. 
Several states that participated in ABCD or Help Me Grow were not DBS high 
performers in this study. Therefore, a state’s involvement in a particular program did not, in 
itself, mean the state had higher DBS rates. It would be important to identify the specific 
components of ABCD and Help Me Grow that each state implemented in order to have a clearer 
understanding of which components were most effective in changing provider practice. These 
components included agency coordination, governor advisory committees, quality of care 
initiatives, stakeholder consensus, provider training, and provision of resources. 
Some states offered reimbursement for screens. However, the states with the highest 
2011/12 DBS rates all had reimbursement rates of under $18 per screen and other research 
suggests that reimbursement is not, on its own, sufficient to increase DBS rates and that 
additional policy changes beyond reimbursement are needed.91 
Massachusetts was most noteworthy in that it had the second highest DBS rate of all the 
states in 2011/12, with a very large (236%) increase from 2007 to 2011/12. Massachusetts 
undertook several steps during the 5-year time period from 2007 to 2011/12 that may have led to 
the large increase. The state enacted a court-ordered mandate (the “Rosie D” case) to screen for 




21), effective January 2008. An analysis of Medicaid claims data showed that, from January 
2008 to December 2009, there was an increase from 16.6% to 53.6% in all Medicaid well-child 
visits with codes for behavioral screens.92 Providers were required to use tools from a list 
provided by the state and were reimbursed approximately $10 for each screen. The state also 
informed primary care providers about the requirements, distributed educational resources, and 
conducted regional educational forums. At the same time, Massachusetts joined the Help Me 
Grow initiative that promotes cross-sector collaboration to create effective early childhood 
systems. In sum, the strategy that was likely most effective in rapidly increasing Massachusetts’ 
screening 3-fold was a judicial mandate to use a validated screening tool; this effect may have 
been enhanced by additional strategies that included a small payment to incentivize providers, 
system coordination, data integration, and provider education. 
North Carolina had the top DBS rate of 58% in 2011/12. In 2000, this state joined the 
first ABCD Consortium cohort that promoted use of DBS in primary care. The state piloted DBS 
and DBM for children regardless of payor. North Carolina’s ABCD program ended in 2003, but 
the screening practice became statewide with a change in Medicaid policy in 200421 and included 
a requirement to provide screening when children attended their well checkups at 6, 12, 18, 24, 
36, 48, and 60 months (as part of a bundled set of preventive health services for children). The 
ABCD program led to a 5-fold increase in DBS among Medicaid well-child visits in North 
Carolina between 2004 and 2008 and referrals to Early Intervention programs quadrupled.93 
Important components of the program included training physicians on how to establish office 
routines to implement screening tools and track patients, and increasing providers’ knowledge of 
how to build up a network of agencies to which to refer.32, 93 The fact that North Carolina had the 




program, associated health care policy around DBS, and focus on provider practice change, may 
have been associated with positive results. However, North Carolina’s ABCD program ended 
and their DBS rate increased by 23% from 2007 to 2011/12, suggesting that the state’s gains 
over that time period were lower than many other states. Since 2016, North Carolina has begun 
reimbursing for screening separate from its bundled payment for preventive health services, and 
this may lead to a larger increase in DBS. 
Delaware responded to their low 10.9% DBS rate in the 2007 survey by passing 
legislation requiring private insurance providers to pay for developmental screening. They also 
used public health funding to provide financial incentives to health care providers to implement 
such screening. They implemented the Help Me Grow program and hired “health ambassadors” 
to help link families of young children to services. Delaware’s DBS rates for children birth to 71 
months increased from 10.9% in 2007 to 30.8% in 2011/12. 
Georgia increased its DBS rate by 80% from 2007 to 2011/12. During that time period, 
Georgia required DBS as part of well-child visits and reimbursed it separately. The state required 
managed-care companies to report their DBS rates, and most of these companies used the same 
reimbursement rate as Medicaid fee for service. Georgia state officials partnered with the AAP, 
advisory committees, and academic institutions to conduct provider trainings and to ensure 
collaboration among their state agencies and between their state and private organizations. 
Pennsylvania had a 29.8% DBS rate in 2011/12, below the national average, but the rate 
had increased by 178% from the 2007 rate. The state implemented statewide DBS for their child 
welfare population beginning in September 2008. Screening was required for children birth to 3 




children up to age 5 who were receiving child welfare agency services. This state policy resulted 
from amendments to the Federal Child Abuse Prevention and Treatment Act (CAPTA). 
The Affordable Care Act (ACA) had a focus on prevention94 and required private health 
plans to cover services specified in the AAP’s Bright Futures pediatric guidelines as of 
September 23, 2010 (with no cost-sharing). However, the survey used for this study was fielded 
in 2011/12 and likely did not reflect gains in screening related to the ACA. The 2016 NSCH 
public data were released during the writing of this report and may provide a more accurate 
picture of changes in DBS rates due to the ACA, however screening rates cannot be compared 
with the 2011/12 data due to changes in the survey methodology for the 2016 NSCH. 
 
STATE VARIATIONS IN MONITORING 
There was significant variation in states’ DBM rates, ranging from 39.8% in Mississippi 
to 66.6% in Vermont. States’ DBS rates did not correlate directly with their DBM rates. There 
were only four states that were above the national mean for both DBS and DBM rates. They 
were Massachusetts, Minnesota, North Carolina, and Tennessee. Two states, Mississippi and 
New Jersey, were below the national mean for both DBS and DBM rates. The top five DBS 
states were North Carolina, Massachusetts, Colorado, Minnesota, and Georgia.  The top five 
DBM states were Vermont, North Carolina, Iowa, Massachusetts and Minnesota. Therefore, the 
three states that ranked in the top five for both DBS and DBM were North Carolina, 
Massachusetts, and Minnesota. It would be informative to pursue further investigation into the 






This section focuses on Medicaid policy because of the disproportionality of 
developmental and behavioral problems among poorer children and the potential role of 
Medicaid policy in shaping provider practice. Primary care providers identify developmental 
delays more frequently and earlier when using standardized DBS tools rather than simply 
eliciting concerns from parents. As discussed above, states have a range of policy levers that may 
incentivize providers to conduct DBS. These policy improvements can be categorized into four 
groups:95 
1. policies to improve provider practice; 
2. policies to improve health care access; 
3. policies to increase public awareness and family engagement; and 
4. policies to improve data and information systems. 
The results of this study, the experiences of high-performing states, and previous scans of 
various state-level activities95,96 suggest that the following strategies should be considered by 
states attempting to increase their DBS rates. 
Policies to Improve Provider Practice 
Providers should be incentivized to conduct universal DBS of children under the age of 3 
as recommended by the AAP, but also to monitor children at every well-child visit, including 
preschoolers ages 3–5. Incentives include mandates/requirements and reimbursement for these 
preventive services, as well as training and technical assistance on incorporating these services 
into practice workflows. 
State Medicaid policies can support provider practice by requiring that DBS be provided 




providers. Any mandate may need to be accompanied by reimbursement although it is likely that 
large payments may not be more effective than small ones. The current study did not find that 
reimbursement policy was associated with a state’s screening rates; however, there were 
limitations to the policy dataset. The question about reimbursement asked simply whether the 
state Medicaid program paid an additional fee for screening and did not take into account the 
range and complexity of reimbursement options that are available to states or how the question 
may have been interpreted by different states. If a state elects to use a financial lever, the 
following are some of the options: (a) mandate screenings if providers want to receive EPSDT 
payments for the parts of the well-child visit they do provide; (b) provide an enhanced rate for 
DBS bundled within the well-child visit payment; (c) reimburse for screening separately from 
the well-child visit using a separate procedural code; (d) pay managed-care organizations a 
financial incentive to increase screening rates; and (e) increase the amount at which DBS is 
reimbursed. Future research should investigate whether one or more of these financial levers are, 
in fact, associated with increased screening rates.  
Provider training and dissemination of resources should accompany DBS. Provider 
training should target health care providers who are already practicing; in addition, universities 
and medical schools should include DBS in their curricula so that newly trained health care 
providers are well prepared to perform DBS once they graduate. Training should cover the 
importance of screening, the selection of screening tools, referral resources, billing codes, and 
protocols to integrate screening into the practice workflow. The Godoy and Carter framework 
places provider–parent conversation and interaction at the heart of the help-seeking process. 




sensitive and attuned to parents’ appraisals and socio-cultural and linguistic backgrounds that 
may affect their response to screening and their help-seeking. 
Policies to Improve Health Care Access 
States should incentivize and promote patient-centered medical homes, especially for 
populations that are less likely to have access to these (Black children, Hispanic children from 
non-English speaking homes, uninsured children, and children on public insurance). Medical 
homes are designed to improve provider–parent communication and general quality of care. 
As providers cite lack of referral options for children who screen positive as a reason for 
not performing DBS, states need to ensure availability of (and broad eligibility for) Early 
Intervention and special education services as well as behavioral health services. Participation in 
the Help Me Grow program with its cross-system coordination could also be helpful. 
Coordination of screening efforts in different child-serving systems (early care and 
education, primary care, early intervention, and child welfare) is important. A state-level cross-
agency task force may be helpful as may be joining nationwide initiatives that promote DBS 
(e.g., the Help Me Grow initiative). 
States should consider including screening of preschool age children in their policies, as 
current guidelines require DBS until age 30 months, but developmental problems are often only 
identified once children reach kindergarten. Therefore, screening at ages 36, 48, and 60 months 
of age (as implemented in North Carolina) could be effective in increasing early identification 
and remediation of developmental concerns. 
Policies to Increase Public Awareness and Family Engagement 
To increase DBS, it is important to target public awareness and knowledge so as to also 




development, developmental milestones, and the benefits of screening and early identification of 
developmental and behavioral concerns, as in the parent component of the Birth to Five: Watch 
Me Thrive campaign.97 Parent advocacy organizations can be helpful allies in engaging families 
and supporting their self-efficacy to report concerns to providers and to navigate service systems. 
Families should be given information in a culturally appropriate manner while simultaneously 
reducing the stigma around developmental and behavioral conditions. 
Providers should be encouraged to elicit parent concerns and to respond to any concern 
reported by a parent. Providers should be fluent in the language of the household or have access 
to a language interpretation service. Providers should be encouraged to reflect on their own 
socio-cultural backgrounds and their implicit racial biases when engaging with parents. They 
should become knowledgeable about the cultures of their patients, including learning about 
differing norms and expectations relating to child development and parenting practices. All 
elements of the DBS process should be culturally sensitive. This includes having tools that are 
appropriate for different racial/ethnic/cultural groups and in languages other than English, and 
utilizing appropriate screening methods/scoring cutoffs for different populations, if 
recommended. Staff should be available to assist parents as they complete the screening tools. 
This is particularly important for parents with limited literacy. 
Policies to Improve Data and Information Systems 
Data systems should support the work of providers by incorporating recommended 
screening tools into electronic medical records so as to integrate DBS into practice workflow. On 
the state level, successful screening efforts would include a data system to track children who 
have been screened and referred, and would require reporting from providers and managed-care 




screens) through claims data. A screening registry and linkage of screening data across agencies 
can be effective. Currently, other than the NSCH, national data on DBS are not available. There 
are several incomplete data sources. The Children’s Health Insurance Program Reauthorization 
Act of 2009 (CHIPRA) includes provisions to strengthen the quality of care provided to children 
in Medicaid and CHIP. It requires the Department of Health and Human Services to create a set 
of key children’s health care quality measures that would be used on a voluntary basis by State 
Medicaid and CHIP programs. Although developmental screening is part of the core set of 
measures, CMS is only permitted to release data if more than half of states report them, which 
has not occurred. 
We conclude that, to increase DBS rates, states may be most successful if they commit to 
improve policies in all four areas: provider practice, health care access, public awareness/family 
engagement, and data/information systems. This would involve instituting policies that ensure all 
children under 5 are insured and have a medical home; DBS is mandated (and possibly 
reimbursed); data systems are available to track DBS and follow-up care; and providers receive 
training to ensure they have the appropriate knowledge and skills. In addition, each state could 
implement a program such as Help Me Grow statewide. This type of initiative offers many 
resources and strategies to support state policies—a centralized access point to track screenings 
and connect children to appropriate services, provider outreach, culturally sensitive family 
engagement and community partnerships. 
 
STUDY LIMITATIONS 
Study limitations include potential sources of bias in the survey data and the limitations 




Potential Sources of Bias in Survey Data 
Surveys are commonly used for public health surveillance of health status, health care 
access, and health outcomes; to guide health policy; and to monitor changes over time and 
progress towards national health objectives.98, 99 Population-based child health surveys, such as 
the NSCH, are an important source of information about children’s developmental and 
behavioral concerns and their use of services. At the same time, these survey data may contain 
several potential sources of bias, including bias relating to nonresponse, recall, and use of proxy 
informants. 
The NSCH national response rate was estimated at 23% for landline and cellphone 
samples combined, with interview completion rates of 54% for the landline sample and 41% for 
the cell phone sample.78 Sampling weights were adjusted to account for nonresponse and a 
nonresponse bias analysis was conducted to determine to what extent the nonresponse bias 
affected survey estimates and how much sampling weight adjustments helped reduce the 
magnitude of the bias.78 Results showed that interviewed people were more likely to live in rural 
areas and other areas with lower household density, higher levels of home ownership, and greater 
percentage of non-Hispanic White people. However, the NCHS concluded that, while response 
biases had a small impact on survey estimates, the adjustment to the weights reduced these biases 
to insignificant levels (maximum estimated bias of 1.14 percentage points and within confidence 
intervals). 
Nonresponse to the NASHP Medicaid survey used in this study is an important 
consideration. Eleven states did not submit completed surveys. An analysis of each of these 




rate above the national mean; five states had DBS rates no different to the national mean; and 
five states had DBS rates below the national mean.  
Measurement error is a key concern when using survey data relating to the precision and 
accuracy of responses to survey questions,100 with systematic error affecting the validity.101 The 
NASHP Medicaid survey included a very simple question asking whether the state reimbursed 
for screening; it is impossible to know whether this was accurately interpreted by respondents 
given the complexity of Medicaid reimbursement issues in different states. With regard to the 
NSCH, the DBS measure was developed for the 2007 NSCH and used in the 2011/2012 NSCH. 
In field testing, the measure was found to produce a small proportion of false positive cases (no 
false negative cases); the developers concluded that the measure may slightly overestimate 
screening or may pick up screening that was conducted in settings outside of primary care, such 
as early care and education or home visiting programs.87 The DBS survey items were not 
designed to assess DBS in early care and education settings, and, so, there may be more DBS 
occurring outside the primary care setting. 
With regard to measurement error in some important covariates, there was little bias 
detected in the insurance coverage estimates (estimates of bias were 0.03% from the frame 
analysis based on the landline sample, 0.16% from the level of effort analysis, and –0.235 from 
the benchmark analysis).77 The estimate of the percent of children with a medical home may 
have been biased upward slightly (estimates of bias were 0.27% from the frame analysis, 1.90% 
from the level-of-effort analysis, and 1.37% from the benchmark analysis).77 
Child health surveys rely on the report of a “proxy” informant who is knowledgeable 
about the child, typically the parent. Validity issues relating to proxy reports have been studied in 




responses from different types of proxy informants. Surveys that rely on subjective judgments 
about health are subject to bias that may derive from the informant’s personality traits (including 
the desire to offer socially acceptable responses), cognitive processes (including interpretation of 
the questions or response options), and factors specific to the health concern (including the 
tendency to exaggerate or minimize symptoms).101–103 This study focused on health care use 
among young children, and many studies have shown that parents are accurate in their reporting 
of their young children’s development and use of clinical care.20,104 
Difficulty with recall may be an important source of bias, and this increases with the 
timing of the assessment in relation to the event. Parents have been found to offer more accurate 
information on simple yes/no questions and on general questions about service use, but be less 
accurate when questions are asked about the quantity and exact type of services used due to 
difficulty distinguishing among different types of services and service providers.102,105 Parent 
reports may also be more accurate for young children than older children as parents spend more 
time with their younger children and have a better sense of their functioning. Parent reports may 
also be more accurate for observable behaviors rather than internal states.106,107 This study 
utilizes parent recall of young children’s health care use in the previous 12 months, which 
reduces potential concerns about parent recall. 
Research has shown that there are discrepancies in the ratings of emotional and 
behavioral problems of children by different informants (parent, child, teacher, etc.).108 In 
clinical settings, information about child behavior and functioning may be gathered from 
multiple informants. In population-based health surveys, this is frequently impractical. This is 
especially the case with telephone surveys. The NSCH relied on the report of one 




informant bias in this study as studies have shown that proxy reports can be accurate for service 
provision and symptoms and behaviors that are observable, and that responses to questions about 
service use may be less susceptible to different accounts by different informants. 
Analytic Limitations 
This study uses cross-sectional survey data and therefore cannot lead to inferences about 
the causes of DBS and DBM receipt. We examine racial disparities in relation to DBS and DBM 
rates. We conceptualize differences in DBM rates by race as potential signs of disparities in 
provider behavior where children of different racial, ethnic, and language backgrounds are 
differentially monitored. 
Interactions between area characteristics and individual level factors could not be fully 
considered in this study.109 The relationship between a state-level policy and an individual 
characteristic may vary across regions—the state-level effect may be stronger or weaker in 
different regions. In other words, the way in which the characteristics of individuals have an 
impact on their being screened in one state may differ to the way in which individual 
characteristics have an impact on their being screened in another state. 
This study used fixed effects that control for state factors that do not vary. When 
accounting for individual and state level characteristics, multilevel modeling using random 
effects has advantages over fixed effect regression when considering cross-level interactions.86 
Although we have used complex survey methods that provide corrected standard errors, we are 
still not allowing for the evaluation of variance within and between clusters that is unaccounted 
for by predictors.110 This study doubled the standard error on each regression to attempt to 




datasets to evaluate the relative variability in DBS and DBM explained by between-state versus 
within-state differences.  
Generalizability 
This study involved a secondary analysis of the NSCH (a large national and state 
representative survey) potentially generating generalizable results. This is the only survey that 
captures representative data on national DBS. The NASHP Medicaid policy dataset is from 2011 
and therefore coincides with the NSCH data collection period, but data were incomplete and did 
not represent all states. The study included other policy information that was descriptive and 
specific to particular states and required a more detailed examination than was possible in this 
study.   
 
FUTURE RESEARCH DIRECTIONS 
It would be informative to gather detailed data on a variety of state level policies and to 
link those data to the NSCH dataset using multilevel modeling analytic methods. In addition, 
screening rates and policy changes could be tracked over time. Longitudinal research could 
provide a more complete understanding of the screening and help-seeking process. This study 
only included children who saw a health care provider and therefore had the opportunity to 
receive a DBS and DBM. It would be interesting to examine the characteristics of children who 
did not see a health care provider. An in-depth case study approach (with several states that are 
promoting DBS and DBM at multiple levels) would be informative to identify specific policy 
strategies that are most predictive of DBS and DBM receipt. Future research could also examine 
the cost-effectiveness of different screening strategies and of the specific reimbursement rates 




on provider behavior, including the implicit biases of providers in deciding which populations of 
children to screen and to monitor. Screening tools should be culturally appropriate and normed 




The identification of developmental and behavioral difficulties among young children is 
key to ensure their access to early intervention and special education services that improve 
developmental outcomes. It is a positive sign that DBS rates increased from 2007 to 2011/12, 
however they remained low. DBM rates were higher, but DBM was unevenly applied across 
racial/ethnic and language groups. Practice guidelines from professional organizations 
recommend that providers conduct DBM with all children at every well-child visit and also use 
standardized DBS tools with all children at 9, 18, and 30 (or 24) month visits. Provider practice 
is far from meeting these standards. 
There are racial disparities in the identification of, and intervention for, developmental 
and behavioral problems. This study showed that children of color, uninsured children, and 
children who did not have a medical home were all less likely to receive DBM/surveillance by a 
health care provider. Universal DBS in primary care may help reduce disparities in the 
identification of developmental and behavioral problems as DBS that is embedded within a 
primary care practice relies less on a provider’s behavior/communication with a parent than 
DBM.  
States have access to several potentially powerful policy levers to increase DBS and 




legislative, and regulatory mandates; reimbursement across Medicaid fee-for-service and 
Medicaid managed-care systems; collaborative statewide cross-agency initiatives (e.g., Help Me 
Grow); provider training and education; and improved data systems for tracking and reporting of 
DBS. It is also important to promote linguistic and cultural competence in conducting DBS, 
using appropriate DBS tools, explaining results and engaging parents to act on the results. 
DBS of young children is an important public health issue because it increases the 
likelihood of early identification of, and intervention for, developmental concerns; this is known 
to improve child outcomes. This study suggests that DBS may be particularly important for the 
identification of developmental problems among Black children and non-English speaking 
Hispanic children. These groups receive relatively less DBM than White children and, therefore, 
are even less likely than White children to have their developmental and behavioral concerns 
identified based on DBM alone. This study found DBS rates did not differ by race/ethnicity and 
suggests that universal DBS is a potentially more equitable approach that may help reduce racial 
disparities in young children’s developmental and behavioral outcomes. More concerted action is 
needed at the state level to ensure young children are screened and then referred for intervention 
if needed. Use of a combination of state-level screening policies as well as targeted strategies for 
high-risk populations can increase identification of developmental and behavioral conditions 






Table 1. List of Variables Included in Aim 1 Analyses 
 
Type of variable Variable Description Coding 
Dependent variable DBS  Parent filled out 
questionnaire on 




Derived. Dichotomous (yes/no) 










combined with primary 
language 
Derived. Categorical (White, 
non-Hispanic, Black, non-
Hispanic, Hispanic English 
speaking, Hispanic non-English 
speaking, Multiracial/other 
race/language categories) 
 Sex Sex of child Categorical (male/female) 
 Age Age of child at time of 
interview 
Categorical using 3 categories (0–
23 mo, 24–35 mo, 36–71 mo) and 
2 categories (0–35mo, 36–71mo) 
 Family 
income 
Poverty level for 
household based on 
DHHS poverty 






400% and above FPL 
 Mother’s 
education 
Mother’s highest grade 
or year of school 
completed 
Derived. Categorical, Below high 
school; high school; above high 
school 
Covariates: 




Type of insurance of 
child 
Derived. Categorical. 
Public such as Medicaid of 
SCHIP; Private health insurance. 
Currently uninsured. 
 Usual place 
for care 
Child has place usually 
goes when sick or 
parent needs advice  
Derived. Dichotomous (yes/no) 
 Personal 
doctor 
There is a person(s) that 
parent considers child’s 
personal doctor or nurse 
Derived. Dichotomous (yes/no) 
 Medical home Coordinated, ongoing, 
comprehensive care 
within a medical home 
Derived. Dichotomous (care does 
not meet medical home 










Parent has one or more 
concerns on the PEDS 
Categorical (yes/no) 





CSHCN screener Derived. Dichotomous (yes/no) 
State State of 
residence 





Description: Variables from the National Survey of Children’s Health (NSCH) 2011/2012 dataset. 
Used as dependent variables and socio-demographic, health care access and developmental risk 
covariates in the analyses. 





Table 2. List of Variables Included in Aim 2 Analyses 
 
Type of variable Variable Description Coding 
Dependent variable DBS  Parent filled out 
questionnaire on concerns 
about child’s development, 
communication, behavior 
Derived. Dichotomous (yes/no) 
 DBM Doctor asked parent about 









with primary language 
Derived. Categorical (White, non-
Hispanic, Black, non-Hispanic, 
Hispanic English speaking, 








Poverty level for 
household based on DHHS 












Type of insurance of  child Derived. Categorical. 
Public such as Medicaid of 
SCHIP. Private health insurance. 
Currently uninsured. 
 Medical  
home 
coordinated, ongoing, 
comprehensive care within 
a medical home 
Derived. Dichotomous. Care does 
not meet medical home criteria, 






Parent has one or more 
concerns on the PEDS 
Categorical (yes/no) 




CSHCN Screener Derived. Dichotomous (yes/no) 
 
Description: Variables from the National Survey of Children’s Health (NSCH) 2011/2012 dataset. 
Used as dependent variables, primary independent variables and socio-demographic, health care 
access and developmental risk covariates in the analyses. 





Table 3. List of Variables Included in Aim 3 Analyses 
 
Type of variable Variable Description Coding 
Dependent variable DBS  Parent filled out 
questionnaire on 








State policy 1 






Two questions about 
Medicaid policy 
(requirement for DBS 
in well-child visits 
and payment of an 
additional fee for 
DBS) – data available 
for 39 states and DC 
State requires DBS and pays 
additional fee; State requires 
DBS but does not pay additional 
fee; State does not require DBS 
but does pay additional fee; 
State does not require DBS and 
does not pay additional fee. 
 DBS required 
or reimbursed 
Derived from 4 
response options 
Derived (Dichotomous (yes/no) 




Type of insurance of  
child 
Derived. Categorical. 
Public such as Medicaid of 
SCHIP; Private health insurance; 
Currently uninsured. 
 Medical home coordinated, ongoing, 
comprehensive care 
within a medical 
home 
Derived. Dichotomous. Care 
does not meet medical home 
criteria, care meets medical 
home criteria 
 
Description: Variables from the National Survey of Children’s Health (NSCH) 2011/2012 dataset 
and the National Academy for State Health Policy (NASHP) 2011 survey dataset. Used as 
dependent variables, primary independent variables and socio-demographic, health care access and 
developmental risk covariates in the analyses. 





Table 4. Socio-Demographic Characteristics of the Study Population 
Description: Data from the National Survey of Children’s Health (NSCH) 2011/2012, 
representative of the approximately 24.12 million children birth to 71 months in the United States, 
according to the American Community Survey. 
+ Total Hispanic sample is 26.3%.  We divided this group into Hispanic children with English as 
the primary household language and Hispanic children with languages other than English as their 
primary household language.  
Table contains weighted percentages and 95 percent confidence intervals for study population’s 
socio-demographics. 









Children 0–71m who saw 
health care provider in 
previous 12 months 
(N=27,825) Weighted % 
~22.02 million 
95% CI for 
children 0–71m 
who saw health 
care provider in 
previous 12 months 
National total     
Age     
0–35 mo  48.16 48.59 47.3–49.9 




Male 51.0 51.12 49.8–52.4 




White, non-Hispanic 50.1 51.74 50.4–53.0 
Black, non-Hispanic 12.17 11.89 11.1–12.8 
Hispanic/English + 11.16 10.98 10.0–12.0 
Hispanic/non-English + 15.16 13.97 12.9–15.2 
Multiracial/other 11.37 11.42 10.6–12.3 
Family income (Federal 
poverty level)  
 
 
0%–99% FPL 26.13 24.59 23.4–25.8 
100%–199% FPL 21.78 21.36 20.3–22.5 
200%–399% FPL 26.81 27.40 26.3–28.6 
400% FPL or greater 25.28 26.64 25.6–27.7 
Mother’s education  
 
 
Less than high school 14.75 13.22 12.2–14.3 
High school 21.98 21.34 20.2–22.6 




Table 5. Characteristics of the Study Population by Health Care Access 
Description: Data from the National Survey of Children’s Health (NSCH) 2011/2012, 
representative of the 24.12 million children birth to 71 months in the United States, according to the 
American Community Survey. 
Table contains weighted percentages and 95 percent confidence intervals for study population’s 
health care access. 











National total    
Type of Health Insurance       
Public 43.66 42.41 41.1–43.7 
Private 51.7 53.8 52.5–55.1 
None/uninsured 4.66 3.79 3.2–4.4 
Has Usual place for care  
 
  
One or more 94.29 95.37 94.7–96.0 
No 5.71 4.63 4.0–5.3 
Has Personal doctor  
 
  
One or more 91.34 92.61 91.8–93.4 
No 8.66 7.39 6.7–8.2 
Child receiving coordinated, ongoing, 
comprehensive care within a medical home  
 
 
Yes 58.24 58.73 57.4–60.1 














Parent concerns    
One or more 40.06 40.10 38.8–41.4 
None 59.94 59.90 58.6–61.2 
Child with Special Health Care 
Need (CSHCN)  
 
  
Yes 11.36 11.90 11.1–12.7 
No 88.64 88.1 87.3–88.9 
 
Description: Data from the National Survey of Children’s Health (NSCH) 2011/2012, 
representative of the 24.12 million children birth to 71 months in the United States, according to the 
American Community Survey. 
+ Total Hispanic sample is 26.3%.  We divided this group into Hispanic children with English as 
the primary household language and Hispanic children with languages other than English as their 
primary household language.  
Table contains weighted percentages and 95 percent confidence intervals for study population’s 
developmental risk. 






Table 7. Racial/Ethnic Differences in Measures of Health Care Access  
 
  Insurance type (Weighted %) Has a medical  
Race/ethnicity Public Private Uninsured home 
White, non-Hispanic 28% 68% 4% 71% 
Black, non-Hispanic 67% 30% 3% 49% 
Hispanic/English+  46% 47% 6% 55% 
Hispanic/non-English+ 80% 12% 8% 31% 
Multiracial/other 36% 61% 4% 54% 
 
Description: Data from the National Survey of Children’s Health (NSCH) 2011/2012. Children age 
0–71 months who received at least one health care visit in previous 12 months (N=27,825).  
+ Total Hispanic sample is 26.3%.  We divided this group into Hispanic children with English as 
the primary household language and Hispanic children with languages other than English as their 
primary household language.  






Table 8. Rates of DBS and DBM by Socio-Demographics 
Description: Data from the National Survey of Children’s Health (NSCH) 2011/2012. Children age 
0–71 months who received at least one health care visit in previous 12 months (N=27,825).  
+ We divided the Hispanic children into Hispanic children with English as the primary household 
language and Hispanic children with languages other than English as their primary household 
language.  
Using chi-squared test, prevalence is higher for ≥ 1 other category of children within this variable 
at the ***p < 0.001 level of significance; ** p < 0.01 level of significance; * p<0.05 level of 
significance. 





 Rates of DBS         Rates of DBM      
National average 30.8 51.8 
Age   
0–35 mo       38.0***          56.0***        
36–71 mo  26.2 47.9 
Sex   
Female 30.4 51.4 
Male 31.2 52.2 
Race/ethnicity   
White, non-Hispanic 29.9      58.7
***
 
Black, non-Hispanic 31.7 45.6 
Hispanic/English+  29.8 51.1 
Hispanic/non-English+ 34.5 35.7 
Multiracial/other 31.2 49.4 
Family income (Federal Poverty Level)   
0%–99% FPL 31.8 43.7 
100%–199% FPL 31.3 49.6 
200%–399% FPL 29.7 55.1 
400% FPL or greater 30.5      57.9
***
 
Mother’s education   
Less than high school 29.8 39.9 
High school 31.9 46.8 




Table 9. Rates of DBS and DBM by Health Care Access 
 
Description: Data from the National Survey of Children’s Health (NSCH) 2011/2012. Children age 
0–71 months who received at least one health care visit in previous 12 months (N=27,825).  
+ We divided the Hispanic children into Hispanic children with English as the primary household 
language and Hispanic children with languages other than English as their primary household 
language.  
Using chi-squared test, prevalence is higher for ≥ 1 other category of children within this variable 
at the ***p < 0.001 level of significance; ** p < 0.01 level of significance; * p<0.05 level of 
significance. 






 Rates of DBS Rates of DBM 
National average 30.8 51.8 
Type of Health Insurance   
Public 31.5 46.3 
Private 30.7      57.6*** 
None/uninsured 24.5 38.3 
Had Usual place for care   
Yes, one or more places  30.8     52.5** 
No 31.6 37.8 
Had Personal doctor   
Yes, one or more persons 31       53.2*** 
No 28.9 35.2 
Child receiving coordinated, ongoing, 
comprehensive care within medical home  
  
Yes 32.2      59.4*** 




Table 10. Rates of DBS and DBM by Developmental Risk  
 
Description: Data from the National Survey of Children’s Health (NSCH) 2011/2012. Children age 
0–71 months who received at least one health care visit in previous 12 months (N=27,825).  
+ We divided the Hispanic children into Hispanic children with English as the primary household 
language and Hispanic children with languages other than English as their primary household 
language.  
Using chi-squared test, prevalence is higher for ≥ 1 other category of children within this variable 
at the ***p < 0.001 level of significance; ** p < 0.01 level of significance; * p < 0.05 level of 
significance. 




 Rates of DBS Rates of DBM 
National average 30.8 51.8 
Parent concerns   
One or more 29.6 51.3 
None 31.7 52.6 
Child with Special Health Care Need    
Yes      36.7*** 64.7*** 




Table 11. Rates of DBS and DBM, Observed and Expected 




DBS only 8.3% 14.9% 
DBM only 29.4% 35.9% 
Both DBS and DBM 22.6% 16.1% 
Neither DBS nor DBM 39.7% 33.2% 
 
Description: Data from the National Survey of Children’s Health (NSCH) 2011/2012. Children age 
0–71 months who received at least one health care visit in previous 12 months (N=27,825).  






Table 12. Predictors of Children Having a Medical Home 
 
  In Medical Home  
Odds Ratios 
Confidence intervals for Odds 
Ratios  
Age   
 
0–35 mo  1.28~ 0.98–1.69  
36–71 mo  Reference 
 




Male 0.84~ 0.70–1.02 
Race/ethnicity   
 
White, non-Hispanic Reference 
 
Black, non-Hispanic  0.49*** 0.37–0.64 
Hispanic/English+  0.57*** 0.38–0.87 
Hispanic/non-English+  0.25*** 0.21–0.30 
Multiracial/other  0.52*** 0.39–0.70 




Public  0.57*** 0.45–0.72 
Private Reference 
 
Uninsured  0.36*** 0.24–0.54 
 
Description: Data from the National Survey of Children’s Health (NSCH) 2011/2012. Children age 
0–71 months who received at least one health care visit in previous 12 months (N=27,825).  
+ We divided the Hispanic children into Hispanic children with English as the primary household 
language and Hispanic children with languages other than English as their primary household 
language.  
Significance was determined after doubling the standard error in each regression model to counter 
the potential for hierarchical nested data to result in incorrect standard errors and therefore biased 
inferences. 
***p < 0.001 level of significance; ** p < 0.01 level of significance; * p < 0.05 level of significance. 
~ p < 0.10 














2007 to 2011/12 
National totals  19.5% 30.8% 58% 
Age     
 0–11 mo        26.7***         43.4 ***  63%  
12–23 mo  22.5 37.9    68% 
24–35 mo  22.0 37.1 69% 
36–71 mo  17.4 26.2 51% 
Sex     
Female 19.2 30.4 58% 
Male 19.8 31.2 58% 
Race/ethnicity     
White, non-Hispanic 18.6 29.9 61% 
Black, non-Hispanic       24.4***  (1131.7 30% 
Hispanic/English  19.6 29.8 52% 
Hispanic/non-English 18.7 34.5 84% 
Multiracial/other 20.3 31.2 54% 
Family income (Federal 
Poverty Level)     
0%–99% FPL       22.4*** 31.8 42% 
100%–199% FPL 21.6 31.3 45% 
200%–399% FPL 18.5 29.7 61% 
400% FPL or greater 17.0 30.5 79% 
Mother’s education     
Less than high school 21.2 29.8 41% 
High school 21.5 31.9 48% 
More than high school 19.0 31.0 63% 
Type of Health Insurance     
Public       23.6*** 31.5 33% 
Private 17.8 30.7 72% 
None/uninsured 14.8 24.5 66% 
Child with Special Health 
Care Need    
Yes       23.9***      36.7*** 54% 
No 18.9 29.9 58% 
 
Description: Column 2–Data from the National Survey of Children’s Health (NSCH) 2011/2012. 
Children age 0–71 months who received at least one health care visit in previous 12 months  
(N=27,825).  
+ We divided the Hispanic children into Hispanic children with English as the primary household 
language and Hispanic children with languages other than English as their primary household 
language.  
Using chi-squared test, prevalence is higher for ≥ 1 other category of children within this variable 
at the ***p < 0.001 level of significance; ** p < 0.01 level of significance; * p < 0 .05 level of 
significance. 





Table 14. Association between Race/Ethnicity and Receipt of DBS  
 
 Received DBS 
Odds Ratios 
Confidence intervals for 
Odds Ratios 
Race/ethnicity   
White non-Hispanic reference  
Black non-Hispanic 1.16 0.71–1.89 
Hispanic/English+ 1.20 0.63–2.27 
Hispanic/non-English+ 1.65 0.66–4.10 
Multiracial/Other 1.15 0.72–1.85 
Age   
0–35 months  1.77* 1.10–2.84 
36–71 months reference  
Sex   
Male 1.04 0.79–1.36 
Female reference  
Household income   
0%–99% FPL 1.03 0.59–1.79 
100%–199% FPL 1.04 0.65–1.65 
200%–399% FPL 0.97 0.70–1.34 
400% FPL or greater reference  
Mother’s education   
Less than high school reference  
High school graduate 1.18 0.61–2.30 
More than high school 1.17 0.60–2.28 
Insurance type   
Private health insurance reference  
Public insurance  0.94 0.63–1.40 
Currently uninsured 0.75 0.37–1.50 
Medical home   
No reference  
Yes 1.11 0.80–1.54 
Parent-reported concerns   
None  reference  
1 or more  0.86~ 0.71–1.01 
Child with special health care need   
No reference  
Yes 1.48 0.84–2.61 
Description: Data from the National Survey of Children’s Health (NSCH) 2011/2012. Children age 
0–71 months who received at least one health care visit in previous 12 months (N=27,825).  
+ We divided the Hispanic children into Hispanic children with English as the primary household 
language and Hispanic children with languages other than English as their primary household 
language.    Significance was determined after doubling the standard error in each regression 
model to counter the potential for hierarchical nested data to result in incorrect standard errors 
and therefore biased inferences. 95% confidence intervals are reported except for parent-reported 
concerns. 
***p < 0.001 level of significance; ** p < 0.01 level of significance; * p < 0.05 level of 




Table 15. Association between Race/Ethnicity and Receipt of DBM  
 Received DBM  
Odds Ratios 
Confidence intervals for 
Odds Ratios  
Race/ethnicity   
White non-Hispanic reference  
Black non-Hispanic  0.75* 0.59–0.99 
Hispanic/English+ 1.03 0.65–1.64 
Hispanic/non-English+   0.65* 0.47–0.90 
Multiracial/Other 0.84 0.62–1.15 
Age   
0–35 months  1.49* 1.05–2.12 
36–71 months reference  
Sex   
Male 1.01 0.80–1.28 
Female reference  
Household income   
0%–99% FPL 0.90 0.59–1.36 
100%–199% FPL 0.96 0.66–1.38 
200%–399% FPL 1.01 0.74–1.38 
400% FPL or greater reference  
Mother’s education   
Less than high school reference  
High school graduate 1.00 0.61–1.65 
More than high school 1.18 0.67–2.09 
Insurance type   
Private insurance reference  
Public insurance  0.94 0.67–1.32 
Currently uninsured  0.66~ 0.45-0.98 
Medical home   
No reference  
Yes   1.75* 1.12–2.74 
Parent-reported concerns   
None  reference  
1 or more  1.12 0.84–1.48 
Child with special health care need   
No reference  
Yes 2.02~ 1.08–3.79 
 
Description: Data from the National Survey of Children’s Health (NSCH) 2011/2012. Children age 0–71 
months who received at least one health care visit in previous 12 months (N=27,825).  
+ We divided the Hispanic children into Hispanic children with English as the primary household language 
and Hispanic children with languages other than English as their primary household language.  
Significance was determined after doubling the standard error in each regression model to counter the 
potential for hierarchical nested data to result in incorrect standard errors and therefore biased inferences. 
95% confidence intervals are reported except for Uninsured children and Children with Special Health Care 
Need 
***p < 0.001 level of significance; ** p < 0.01 level of significance; * p < 0.05 level of significance; ~ p < 0.10.  








Description: Rates of screening for children birth to 71 months whose parent completed a 
standardized DBS questionnaire in the previous 12 months (2011–2012). Data from the NSCH 
2001/12 dataset. 




Figure 7. DBM Rates by State 
 
Description: Rates of monitoring for children birth to 71 months whose parent was asked by a 
health care provider if they had concerns about their child’s learning, development, or behavior. 





Table 16. Variation in DBS and DBM Prevalence across States, 2011/12 
State DBS prevalence 
Above or below 
national average of 
30.8% (p < 0.05) 
DBM prevalence 
Above or below 
national average of 
51.8% (p < 0.05) 
AK 32.6  57.7   
AL 24.7 – 50.6   
AR 26.3  50.7   
AZ 21.7 – 53.1   
CA 28.5  43.7 – 
CO 47.0 + 56.6   
CT 26.6  53.1   
DC 21.4 – 49.7   
DE 30.8  51.9   
FL 24.0 – 47.3   
GA 40.8 + 50.9   
HI 38.9 + 51.9   
IA 34.3  62.9 + 
ID 25.0  54.1   
IL 34.4  55.7   
IN 23.9 – 51.6   
KS 37.0  59.8 + 
KY 26.3  52.3   
LA 37.3  47.1   
MA 55.1 + 62.8  + 
MD 31.8  53.5   
ME 27.3  58.1 + 
MI 25.3  57.3   
MN 43.8 + 62.1 + 
MO 28.2  62.0 + 
MS 17.5 – 39.8 – 
MT 22.9 – 49.1   
NC 58.0 + 65.8 + 
ND 20.7 – 49.1   
NE 32.3  51.9   
NH 30.6  61.0 + 
NJ 25.0 – 45.1 – 
NM 38.3 + 50.5   
NV 21.9 – 45.8   
NY 21.3 – 47.8   
OH 27.8  59.7 + 
OK 29.5  49.5   
OR 34.4  55.2   
PA 29.8  55.2   
RI 31.5  56.0   
SC 30.1  46.0   
SD 23.5 – 51.9   
TN 38.3 + 60.0 + 
TX 30.4  43.8 – 
UT 26.8  61.2 + 
VA 29.1  50.4   
VT 32.1  66.6 + 
WA 29.9  61.5 + 
WI 33.7  61.1 + 
WV 37.7 + 56.5   





Table 17. Increase in DBS Rates by State from 2007 to 2011/12 
 
State DBS 2007 DBS 2011/12 
Percentage point 
increase 
(amount of change) 
Percent increase 
from 2007  
(rate of change) 
Massachusetts 16.4 55.1 38.7 236% 
Delaware 10.9 30.8 19.9 183% 
Pennsylvania 10.7 29.8 19.1 179% 
Oregon 13.5 34.4 20.9 155% 
Rhode Island 14.5 31.5 17.0 117% 
Alabama 12.1 24.7 12.6 104% 
California 14.0 28.5 14.5 104% 
New Jersey 12.7 25.0 12.3 97% 
Iowa 18.7 34.3 15.6 83% 
New York 11.7 21.3 9.6 82% 
Colorado 25.9 47.0 21.1 81% 
Georgia 22.7 40.8 18.1 80% 
Vermont 17.9 32.1 14.2 79% 
Nebraska 18.8 32.3 13.5 72% 
Kentucky 15.5 26.3 10.8 70% 
New Hampshire 18.1 30.6 12.5 69% 
Arkansas 15.9 26.3 10.4 65% 
Illinois 21.1 34.4 13.3 63% 
Connecticut 16.6 26.6 10.0 60% 
Virginia 18.2 29.1 10.9 60% 
Texas 19.2 30.4 11.2 58% 
South Carolina 19.1 30.1 11.0 58% 
Alaska 20.7 32.6 11.9 57% 
Kansas 24.7 37.0 12.3 50% 
District of Columbia 14.3 21.4 7.1 50% 
Missouri 19.0 28.2 9.2 48% 
Hawaii 27.2 38.9 11.7 43% 
Maryland 22.3 31.8 9.5 43% 
Wyoming 20.2 28.8 8.6 43% 
Oklahoma 20.8 29.5 8.7 42% 
Florida 17.1 24.0 6.9 40% 
Michigan 18.2 25.3 7.1 39% 
Idaho 18.1 25.0 6.9 38% 
Montana 16.7 22.9 6.2 37% 
Ohio 20.8 27.8 7.0 34% 
Tennessee 29.0 38.3 9.3 32% 
Wisconsin 25.9 33.7 7.8 30% 
Utah 20.6 26.8 6.2 30% 
Louisiana 28.7 37.3 8.6 30% 
New Mexico 29.6 38.3 8.7 29% 
Maine 21.5 27.3 5.8 27% 
Arizona 17.3 21.7 4.4 25% 
South Dakota 18.8 23.5 4.7 25% 
North Carolina 47.0 58.0 11.0 23% 
Indiana 19.4 23.9 4.5 23% 
West Virginia 31.9 37.7 5.8 18% 
Nevada 18.6 21.9 3.3 18% 
North Dakota 17.6 20.7 3.1 18% 
Washington 25.6 29.9 4.3 17% 
Minnesota 41.6 43.8 2.2 5% 











Fee for DBS 
Requires 
DBS but 
does not Pay 
Additional 
Fee for DBS 
Pays 
Additional 
Fee for DBS 









State did not respond to 
survey 
CO GA AK AR FL 
IA LA AL AZ HI 
IL NC CA DC MD 
KS NY CT MA MO 
MI RI DE ME MS 
PA WY ID NE ND 
TX  IN UT NH 
VA  KY WA NJ 
  MN  SC 
  MT  WI 
  NM  WV 
  NV   
  OH   
  OK   
  OR   
  SD   
  TN   
  VT   
 
Description: Data from the National Academy for State Health Policy survey dataset, 2011. 






Table 19. DBS Rates Related to State Medicaid Policy 
 
State Medicaid policy (n=40) % children in states with this 
policy who were age 0–71 
months on public insurance 
and who received DBS 
(a) 4 categories of response  
Required DBS, Paid additional fee (8 states) 31.9 
Required DBS, No additional fee (6 states) 38.2 
Did not require DBS, Paid additional fee (18 states) 30.4 
Did not require DBS, No additional fee (7 states and DC) 35.1 
(b) Required OR paid?   
Required or paid (32 states) 32.5 
Did not require or pay (7 states and DC) 35.1 
(c) Required?  
Required (14 states) 34.1 
Did not require (25 states and DC) 31.4 
(d) Paid?  
Paid (26 states) 31.1 
Did not pay (13 states and DC) 37.1 
 
Description: Data from the National Survey of Children’s Health (NSCH) 2011/2012. Children age 
0–71 months who received at least one health care visit in previous 12 months (N=27,825) and data 
from the National Academy for State Health Policy survey dataset, 2011.  
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